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Physiologically based pharmacokinetic (PBPK) modeling is a tool used in drug discovery 
and human health risk assessment. PBPK models are mathematical representations of the 
anatomy, physiology and biochemistry of an organism.  PBPK models, using both compound 
and physiologic inputs, are used to predict a drug’s pharmacokinetics in various situations. 
Tissue to plasma partition coefficients (Kp), a key PBPK model input, define the steady state 
concentration differential between the tissue and plasma and are used to predict the volume 
of distribution. Experimental determination of these parameters once limited the 
development of PBPK models however in silico prediction methods were introduced to 
overcome this issue. The developed algorithms vary in input parameters and prediction 
accuracy and none are considered standard, warranting further research. Chapter 2 presents a 
newly developed Kp prediction algorithm that requires only readily available input 
parameters. Using a test dataset, this Kp prediction algorithm demonstrated good prediction 
accuracy and greater prediction accuracy than preexisting algorithms. Chapter 3 introduced a 
decision tree based Kp prediction method. In this novel approach, six previously published 
algorithms, including the one developed in Chapter 2, were utilized. The aim of the 
developed classifier was to identify the most accurate tissue-specific Kp prediction algorithm 
for a new drug. A dataset consisting of 122 drugs was used to train the classifier and identify 
the most accurate Kp prediction algorithm for a certain physico-chemical space. Three 
versions of tissue specific classifiers were developed and were dependent on the necessary 
inputs. The use of the classifier resulted in a better prediction accuracy as compared to the 
use of any single Kp prediction algorithm for all tissues; the current mode of use in PBPK 
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model building. With built-in estimation equations for those input parameters not necessarily 
available, this Kp prediction tool will provide Kp prediction when only limited input 
parameters are available. The two presented innovative methods will improve tissue 
distribution prediction accuracy thus enhancing the confidence in PBPK modeling outputs.   
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Physiologically-based pharmacokinetic (PBPK) modeling 
Pharmacokinetics (PK) is the mathematical description of the absorption, distribution, 
metabolism and excretion (ADME) of a compound and a quantitative description of how these 
processes affect the time course and intensity of response. One means of predicting and assessing 
the pharmacokinetics of a compound is through the use of PBPK modeling. As a result, PBPK 
models are used in pharmaceutical research, drug development and in toxicological risk 
assessment. PBPK models are mathematical constructions that are developed to represent the 
organism of interest. A whole body PBPK model is comprised of physiological compartments 
that represent organs or tissues (Figure 1-1). Each organ is represented as either one well-stirred 
compartment (e.g. one homogenously mixed unit) or as multiple compartments that represent, 
for example, vascular, interstitial and/or intracellular space. Organ compartments are linked 
together through venous and arterial blood pools with closure of the system through the lungs. 
Mass transfer between each compartment identified in the model is represented using a 





Figure 1-1. Structure of PBPK model. (SI: Small intestine, LI: large intestine)  
 
Each  organ compartment within the PBPK model is defined by a species specific blood flow 
rate (the sum of which equals the total cardiac output) and a physiologic volume 
[1]
. Compound 
specific parameters such as protein binding affinity, tissue to plasma partition coefficients, 
clearance and permeability x surface area products (if organs are not considered well-stirred) are 
required for the initial parameterization of a PBPK model. Once a PBPK model is structured and 





Figure 1-2. An example of simulated concentration versus time profile in tissues and the plasma by a 
PBPK model  
 
In early drug discovery, a drug candidate is screened among thousands of possible compounds. 
The empirical approach in the selection of a drug candidate can be time consuming, labor 
intensive and costly. Therefore, drug candidate screening and a first-time-in-animal study design 
can be aided by PBPK modeling for the prediction and understanding of a compound’s ADME. 
Furthermore, PBPK models predict the human PK as early as possible which can help to identify 
undesirable PK characteristics of a drug candidate. Early PK prediction can help to reduce the 
cost associated with drug development and potentially reduce the rate of failure in drug 
development. 
The following steps are taken in PBPK modeling for interspecies scaling. Once compound 
specific parameters (e.g. unbound fraction in plasma, species specific clearance) and species 
specific anatomical and physiological parameters are input, a series of concentration vs. time 
profiles are simulated for any organ or tissue that is included in the model (e.g. Figure 1-2). To 
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ensure appropriate distribution and clearance, a comparison of the simulated and the 
experimentally determined profiles are made. Uncertain input parameters are optimized (e.g. 
tissue to plasma partition coefficients) until there is adequate agreement between the simulated 
and experimentally determined curves. This usually occurs in the rat. Scaling to humans is then 
completed by replacing the anatomical, physiological and biochemical inputs to that of humans 
and re-simulating. This provides a biologically rational approach to interspecies scaling of PK. 
 
Tissue distribution 
The distribution of a compound within a system (i.e. tissue distribution) is the process of 
compound partitioning into the tissues from the systemic circulation. Compound properties (e.g. 
lipophilicity) and the nature of tissue cellular membranes determine the ability of the compound 
to permeate into the tissue. For example, lipophilic compounds tend to partition to a greater 
extent into lipid-rich tissues such as adipose and brain whereas hydrophilic compounds tend to 
distribute into lean tissues such as heart and muscle. The extent of tissue distribution is 
dependent on tissue partitioning and the binding affinity of a compound to blood cells, proteins 
and tissue components 
[1]
. The global parameter that quantifies the extent of compound 
distribution from plasma into tissues is the volume of distribution at steady state (Vss). This is a 
PBPK modeling output. For example, a small Vss indicates a lack of tissue specific binding 
and/or an affinity for binding to plasma proteins. Compounds with a large Vss have extensive 
affinity for binding in tissues. 
Due to various tissue compositions, compound concentration is tissue-specific. The extent of 
compound distribution into an individual tissue is expressed by a steady state tissue to plasma 
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partition coefficient (Kp), i.e. the ratio of the concentration of a compound in tissue and plasma 
[2]
. Thus, the relationship between Vss and Kp is expressed as Eqn.1-1 
[3]
: 




itissueiplasma EVKpVVss    
where Vplasma and Vtissue, is the physiologic volume of plasma and respective tissue. E is the 
extraction ratio of an eliminating tissue (i.e. the liver or the kidneys) and is a measure that 
represents the ability of a tissue to remove a compound from the systemic circulation through 
excretion in the urine or enzymatic metabolism in the liver. For non-eliminating tissue, 
extraction ratio is zero (Ei=0).  
Kps are used to quantify the extent of a compounds distribution from the systemic circulation 
into the tissues at steady-state. The Kps used in PBPK models comprise the tissue: plasma 
partition coefficients based on total (Kp) 
[2,4-6]
 or unbound concentration (Kpu) 
[7-9]
 in the case of 
drug compounds or the tissue: blood partition coefficients 
[10]
 based on total concentration for 
environmental chemicals. The tissue distribution prediction within a PBPK model is sensitive to 
the Kp values. Historically, these values were derived experimentally in vivo. This is a costly and 
time consuming endeavor and has been a limitation in the development of PBPK models. As a 
result, Kp prediction algorithms using in vitro and in silico data have been developed to 
overcome the need for experimental Kp determination. These algorithms predict Kps based on the 
underlying physiology and behavior of a compound in the body.  
Kp prediction algorithms are divided into two areas: (i) tissue composition based (TCB) 
algorithms that are created solely using physico-chemical properties of the compound along with 
tissue specific parameters and (ii) correlation based algorithms that are empirically derived using 
both compound specific information and information derived in vivo (e.g. muscle Kp).  
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Tissue composition based algorithms  
TCB algorithms are mechanistic in nature and do not require in vivo information as input. In 
early studies, tissue solubility of a compound was calculated by assuming: (i) solubility of a 
chemical in n-octanol corresponds to its solubility in tissue neutral lipids, (ii) solubility in water 
corresponds to water fraction and (iii) solubility in phospholipids is a function of solubility in 
water and n-octanol 
[10]
. Using this assumption, the solubility of a chemical in tissue was then 
calculated as the sum of the solubilities listed above 
[11]
. Building on this, a mechanistic model 
based on tissue composition, physico-chemistry, and plasma protein binding was developed by 
Poulin and his coworkers and later revised by Berezhkovskiy 
[12]
. The main assumption of this 
TCB model is that the distribution of a compound is primarily governed by passive diffusion into 
tissue compartments and reversible binding to common proteins that are in the plasma and tissue 
interstitial spaces. 
  
Figure 1-3. A schematic showing the underlying processes of tissue partitioning that were 






Later, Rodgers and Rowland (2005a) extended and enhanced the TCB model by incorporating 
the electrostatic interactions of moderate to strong bases (pKa ≥ 7) with acidic phospholipids to 
predict Kpu. This model assumes that the electrostatic interactions prevail and compounds 
distribute passively into intra- and/or extracellular tissue water. The equation also accounts for 
two processes: (i) dissolution of both ionized and unionized portions of a compound into tissue 
water and (ii) partitioning of unionized compounds into neutral lipids and neutral phospholipids 
(Figure 1-3). The researchers also attempted to predict Kpu which is the steady state parameter 
that relates the unbound concentration in tissues to unbound concentration in plasma. The reason 
for predicting Kpu as opposed to Kp is that only unbound compounds can distribute across 
cellular membranes.  
 Rodgers and coworker(s) 
[9]
 continued to develop a new mechanistic equation for predicting the 
Kps for neutrals, acids, and weak bases by considering the compound interactions with proteins. 
This is an important factor for the tissue distribution of compounds because of the abundance of 
proteins that are present in the extracellular space. Lipophilic neutrals preferentially bind to 
lipoproteins, whereas acids and weak bases primarily bind to albumin. Zwitterions can be 
divided into two groups. The first group includes compounds with one basic form (pKa ≥ 7), thus 
it is presumed to undergo interactions with acidic phospholipids in the same manner that strong 
bases do. The second group consists of all other zwitter-ionic compounds and they are thought to 
have the same distributional behavior as acids and very weak bases 
[8,9]
. Therefore, the degree of 
the affinity of the compounds to the extracellular proteins is a crucial parameter in the prediction 





 built a TCB algorithm to calculate Kps of classes of compounds based on their 
lipophilicity, pKa, binding ability to phospholipids and the unbound fraction in plasma. 
Specifically, compound binding to phospholipids was explained in a mechanistic way by 
accounting for the interaction between charged phospholipids and charged molecules along with  
consideration of the phosphatidylcholine:buffer partition coefficient and the phospholipid:water 
partition coefficient. This model can be applied universally for all classes of compounds, which 
implies the significance of this algorithm. Later, Peryet and his coworkers 
[13]
 developed the 
algorithm that unifies the mechanisms involved in the distribution of both drug compounds and 
environmental chemicals. The unified algorithm provides predictions of Kps by calculating the 
ratio of the concentration in cellular and interstitial space to the concentration in plasma and red 
blood cells (RBC). The Peryet et al. (2010) algorithm also accounted for the consideration of 
different volumes in each matrix. The researchers attempted to integrate and reproduce the 
previously published equations into a single algorithm. Their calculations yielded the same level 
of accuracy when compared to previous studies. In addition, this unified algorithm predicts 
partition coefficients at both the macro (tissue: plasma partition coefficient) and the micro (cells: 




Correlation based algorithms 
The relationship between experimentally determined in vivo parameters (e.g. a muscle Kp) and 
Kps has been utilized to develop predictive regression equations to estimate Kps. The work of 
Bjorkman 
[4]
 demonstrated that muscle Kp can be used to represent other tissue Kps. Specifically, 
lean tissue Kps can be calculated using a linear regression equation with muscle Kp as a 
predictor. The empirical method was later refined by the work of Jansson 
[5]
. For this model, the 
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relationship between muscle Kp and non-adipose Kp was improved by incorporating compound 
lipophilicity data into the equations.  
For moderate-to-strong bases, it was observed that the Kp predictions were less accurate than for 
neutral, acidic and weakly basic compounds 
[8]
. This was mainly due to their ionic interaction 
with acidic phospholipids such as phosphophatidyl serine (PhS). The work of Yata and 
colleagues demonstrated that the inter-organ variation in tissue distribution of basic compounds 
varies with PhS concentration 
[14]
. The study of Poulin and Theil introduced a correlation based 
algorithm that utilized red blood cell partitioning data for unbound compounds (RBCu) 
[7]
. RBCu 
was determined in vitro and used as an indicator of the degree of binding capacity due to 
electronic interactions of basic compounds with acidic PhS. The rationale for this correlation is 
that RBCs are rich in acidic phospholipids and the membrane of RBCs play a similar role to the 
cellular membrane in a lean tissue. In this study, the relationship between RBCu and tissue Kps 
as well as the relationship between muscle Kps and tissue Kps was used to develop predictive 
regression equations. It was observed that Kp prediction with muscle Kp as a predictor was more 
accurate than the use of RBCu as a predictor alone 
[7]
. This approach was further enhanced by 
identifying outliers of the over-prediction of Kps. Both pharmacological activity of a compound 
and compound specific properties such as pKa and lipophilicity were taken into account to refine 




Input parameters for Kp algorithms 
Various input parameters for the introduced algorithms are often determined in vitro and used in 
TCB algorithms to estimate: (i) the hydrophobic interactions of a compound with neutral 
phospholipids (e.g. n-octanol: buffer partition coefficient, or vegetable oil: buffer partition 
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coefficient), (ii) the ionic interaction with charged phospholipids, (iii) hydrophobic binding to 
hemoglobin (e.g. blood: air partition coefficient)  and (iv) the binding to plasma proteins (e.g. 
unbound fraction in plasma). Some of the important parameters in the previously explained 
algorithms are described below.  
Lipophilicity is one of the most important ADME-related properties and has a major impact on 
pharmacokinetics. Lipophilicity of a compound is determined using LogP from octanol/water 
partitioning. LogP is the logarithm of the partition coefficient of the compound trapped between 
an organic phase and an aqueous phase at a pH where all of the compounds are in their neutral 
forms. N-octanol is thought to mimic the hydro-lipophilicity balance of neutral lipid mixtures; 
therefore, the distribution of a compound into n-octanol was postulated to simulate the ability of 
a compound to passively diffuse across biological membranes. However, n-octanol is not a 
suitable surrogate to mimic the triglycerides of adipose tissue. The solution to this would be to 
use olive oil, which is abundant in triglycerides. Therefore the logarithm of olive oil: buffer 
partition coefficient (LogKvo:w) provides a more accurate Kp prediction for adipose tissue 
[8,9,16]
. 
Additionally, LogD is the logarithm of the distribution coefficient of the compound at a specific 
pH. LogD depends on the partitioning of the ionized portion of the molecules and the 
partitioning of the neutral portion of the molecules.  
The fraction of unbound compound in plasma (fup) is also an important descriptor in Kp 
prediction models. Binding of a compound to plasma proteins affects its distribution. The degree 
of binding is frequently expressed as a ratio of bound to total concentration. The unbound 
fraction of a compound is the proportion of the compound in plasma or in tissue interstitial space 
that is not bound to common proteins such as albumin, glycoproteins, lipoproteins and globulins. 
The steady-state concentration of an unbound compound is equal in all body tissues, regardless 
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to the degree of the binding to the macromolecules. Therefore, the value of Kp can be defined as 
the ratio of the fraction of unbound compound in the plasma to the fraction of unbound 
compound in the tissue. Furthermore, the fraction of the unbound compound is regarded to be 
pharmacologically active. Since bound protein-compound complexes cannot penetrate the 
capillary membrane, the rate of distribution of compound into tissue is dependent on the 
concentration gradient produced by the concentration of unbound unionized compound. 
A molecule's pKa, which is a determining factor in the degree of ionization at a particular pH, is 
a key chemical property in Kp predictions. Compounds that are weak acids or weak bases exist in 
solution at equilibrium between the unionized and ionized form. Only un-ionized nonpolar 
chemicals can cross the tissue membrane as ionized compounds are less permeable than un-
ionized compounds. At equilibrium, the concentrations of the un-ionized compounds are equal in 
both plasma and tissue. However, total concentration in one matrix (e.g. a tissue) may be 
different depending on the degree of ionization of a compound at a tissue-specific physiological 
pH. For the statistical analyses in this study, a variable that indicates the degree of ionization of a 
compound as a function of tissue pH is needed. The ionized fraction of the compound (fi) 
represents the degree of ionization at a tissue-specific physiological pH (equations are presented 
in the chapter 2). The fi equations are derived from the Henderson-Hasselbalch equation.  The fi 
value ranges from 0 to 1 where a highly ionized compound at specific pH approaches 1. 
 Figure 1‑4 presents the simulation of fi value at various compound pKas. The influence of 
different tissue pH is demonstrated (i.e. pH 7.4 for plasma, pH 6.6 for lung).  For a compound 
with an acidic pKa where the pKa value is smaller than the tissue pH, the fi is high (Figure 1‑4, 
top). For a compound with a basic pKa where the pKa value is larger than the tissue pH, the fi is 
high (Figure 1‑4, bottom). With knowledge of pKa (acidic or basic pKa), this variable can 
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distinguish the ionized fraction for compounds with the same value of pKa. For example, for a 
compound with acidic pKa of 7, the fi value at the plasma pH 7.4 is 0.72. For a compound with 
basic pKa of 7, the fi value at the plasma pH 7.4 is 0.28. In addition, for a neutral compound, the 
fi value is zero. Thus, fi is considered to be a better representative parameter for describing a 
compound’s degree of ionization at various tissue pH than the use of pKa alone.  
 
 
Figure 1-4. Simulation of degree of ionization at various tissue pH for monoprotic acids (top) and 
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Compound affinity to red blood cells is often used as an indicator of in vivo distribution. It has 
been observed that a compound’s ability to bind to hemoglobin within RBCs correlates with the 
lipophilicity of the compound 
[17]
. Compound binding to RBCs is a crucial factor in representing 
tissue distribution because RBCs are rich in acidic phospholipids, which are responsible for the 
high binding affinity of basic compounds.  Only a few algorithms (e.g. 
[7,8]
) require RBCu. 
Poulin and Theil 
[7]
 demonstrated that the Kp prediction with muscle Kp as an input variable was 
more accurate than the Kp prediction with RBCu as an input variable. The muscle Kp is also an 
important factor in Kp prediction since muscle is a highly perfused organ, and accounts for 
approximately 40% of the total body mass. For compounds with a large Vss, a substantial 
portion of the compound is considered to partition into the muscle.  In addition, Vss also can be 




These physico-chemical and physiological inputs represent key input parameters for Kp 
prediction algorithms. Some of these input parameters are readily available such as a measure of 
lipophilicity or pKa while others are not routinely measured such as RBCu or muscle Kp. Due to 
the difficulty in obtaining some of the input parameters; several algorithms have limited utility in 
tissue-specific Kp prediction for a novel compound.  
 
Thesis objectives 
This thesis aims to enhance the confidence in Kp predictions. First, a novel correlation based 
prediction algorithm is developed that uses readily available inputs. The hypothesis for this study 
was that this correlation based algorithm will increase the tissue specific accuracy in Kp 
prediction for a tissue.  
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Second, a machine learning method is used to develop a decision tree that will select, for each 
tissue, the best-predicting Kp algorithm. This will allow the user to harness the best of all of the 
algorithms for their novel compound. The hypothesis for this study was that the use of a decision 
tree will produce a more accurate overall prediction of Kps than any one Kp prediction algorithm 
alone. This will result in an adequate parameterization of a PBPK model. These two innovative 
methods will improve tissue distribution prediction accuracy therefore enhancing the confidence 








Correlation-based prediction of tissue-to-plasma partition coefficients using 




1. Rationale: Tissue-to-plasma partition coefficients (Kp) that characterize the tissue 
distribution of a drug are important input parameters in physiologically based 
pharmacokinetic (PBPK) models. The aim of this study was to develop an empirically 
derived Kp prediction algorithm using input parameters that are available early in the 
investigation of a compound.  
2. Methods: The algorithm development dataset (n = 97 compounds) was divided according 
to acidic/basic properties. Using multiple stepwise regression, the experimentally derived 
Kp values were correlated with the rat volume of distribution at steady state (Vss) and one 
or more physicochemical parameters (e.g., lipophilicity, degree of ionization, protein 
binding) to account for inter-organ variability of tissue distribution.  
3. Results: Prediction equations for the value of Kp were developed for 11 tissues. 
Validation of this model using a test dataset (n = 20 compounds) demonstrated that 65% 
of the predicted Kp values were within a two-fold error deviation from the experimental 
values. The developed algorithms had greater prediction accuracy compared to an 
existing empirically derived and a mechanistic tissue-composition algorithm.  
                                                     
a
 Chapter 2 has been published in the journal Xenobiotica. 
Yun, Y. E. & Edginton, A. N. 2013, "Correlation-based prediction of tissue-to-plasma partition coefficients using 
readily available input parameters", Xenobiotica 43: (In press). doi 10.3109/00498254.2013.770182 
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4. Conclusions: This innovative method uses readily available input parameters with 
reasonable prediction accuracy and will thus enhance both the usability and the 
confidence in the outputs of PBPK models.   
 
2.2 Introduction  
Physiologically based pharmacokinetic (PBPK) modeling is widely used in pharmaceutical 
research, drug development and toxicological risk assessment to make predictions of the target 
tissue exposure following various administration scenarios 
[20]
. An inherent advantage of PBPK 
approaches is the ability to incorporate both intrinsic (e.g., age, organ dysfunction 
[21,22]
) and 
extrinsic (e.g., drug-drug interaction 
[23]
) factors into the models, which provides the ability to 
make biologically plausible PK predictions and extrapolations across and within species 
[24]
. A 
PBPK model uses anatomically and physiologically appropriate compartments of a body (e.g., 
tissues), which are linked through systemic circulation with the system closed through the lung 
[3,25-27]
. In addition to organ-specific inputs, PBPK models also require drug-specific inputs, such 
as a measure of the binding affinity to plasma proteins (fup), the tissue to plasma partition 
coefficients (Kp), the permeability × surface area products and the drug dissolution properties. 
Although anthropometric parameters are available for many organisms, drug-specific inputs are 
more uncertain and just as crucial to the success of the model prediction.  
One of the most important drug-specific input parameters is the tissue to plasma partition 
coefficients, Kp, i.e., the ratio of the concentration of a compound in the tissue to the 
concentration of the compound in the plasma at steady state 
[2,6]
. The value of this coefficient 
indicates the degree of accumulation of a drug in a tissue under steady-state conditions and 
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represents the relative exposure of a drug between different tissues, which enables a target site-
related assessment of absorption, distribution and elimination 
[28]
. 
The Kp values partially define the volume of the distribution at steady state (Vss), which is the 
ratio of the total amount of the drug in the body to the total amount of the drug in the plasma 
under steady-state conditions 
[29-31]
. The Vss value represents the overall extent of the drug 





itissueiplasma EVKpVVss     
where Vplasma is the volume of the plasma and Vtissue,i is the volume of the i
th
 tissue. For non-
eliminating tissues, extraction ratio Ei is zero (Ei=0). If the model is parameterized with the 
appropriate Kp values, PBPK models can predict the Vss because the plasma and tissue volumes 
are inherent parameters in the model. 
 
The Kp values can be experimentally derived in rodents through destructive sampling and are 
generally considered to be the most desirable input parameters because their uncertainty is low. 
However, the experimental in vivo determination of these Kp values can be misleading if steady 
state is not reached at the time of the measurement; for example, highly lipophilic molecules 
require a longer time to reach steady state than the time that researchers might be willing to wait. 
This experimental determination of these parameters is also time consuming and expensive 
[6,32]
. 
As a result, to minimize the need of experimental procedures in animals, algorithms that predict 
the Kp values based on the physico-chemical characteristics of the compound and organism-
specific parameters have been developed. Two types of algorithms exist: mechanistic algorithms 
and empirically derived algorithms. 
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Tissue composition-based (TCB) algorithms are mechanistic in nature and provide initial 
estimation of the Kp values when in vivo information (e.g., muscle Kp) is unavailable. TCB 
modeling aims to describe the combination of the interactions that occur in any one tissue as a 
result of the physiological components of the tissue and the chemical properties of the compound 
[2,6,8,9]
.  In early TCB models 
[2,2,10]
, the tissue-to-blood partition coefficients were predicted by 
estimating the ratio of the solubility of a chemical in tissues to that in blood. The solubility in 
each matrix was approximated as the total solubility of the compound in neutral lipids, 
phospholipids, and water. Rodgers et al. enhanced these models by incorporating the electrostatic 
interactions of basic compounds (pKa ≥ 7) with cellular acidic phospholipids 
[8]
. With neutral, 
acidic, and weak basic compounds, the prediction of Kp values is primarily defined by their 
interaction with extracellular proteins (i.e., lipoproteins, albumin) 
[9]
.  Further modifications to 
the model were made by Schmitt 
[6]
, who accounted for the combination of the effects of the drug 
distribution in the interstitial space, the effects of the pH gradient between the plasma and the 
tissues, the partitioning into the different lipid components in the tissues, and the binding to 
proteins.   
Correlation-based Kp prediction models are empirical in nature and offer an alternative approach 
to the TCB models. These correlation-based models use both physicochemical descriptors of a 
compound 
[5]
 and organism-specific data, such as muscle Kp 
[4,5,7]
 and red blood cell partitioning 
data 
[7]
 as predictor variables.  Early correlation-based models used an experimentally 




 performed similar work but also used adipose Kp values as a predictor 
[4]
. The 
work of Jansson et al. 
[5]
 enhanced Poulin and Theil’s 
[29]
 approach by incorporating the 




uses Kp,muscle as the ultimate input parameter.  If the value of Kp,muscle is not available, equation 
2 can be used to generate the value of this parameter from Vss.   






, 10  
[5]
 
The Jansson et al. 
[5] 
method requires either an experimentally derived value for the muscle Kp or 
the value of Vss, which can be used to predict the value of Kp,muscle. This parameter is then used in 
the regression equations. Poulin and Theil 
[7]
 proposed a correlation model that utilized red blood 
cell partitioning data for unbound drugs (RBCu) as an indicator of the degree of the binding 
capacity of basic drugs with acidic phosphatidylserines.   
Recently, a comparison of the current methods for the determination of Vss based on the 
estimation of Kp and the use of Eqn.2-2 found that the correlation-based models, especially 
Jansson et al. model 
[5]
, were more accurate than even the best TCB model, which was developed 
by Rodgers et al. 
[33,34]
. The results suggest that the correlation-based methods have a higher 
accuracy in Kp prediction; however, these models also require input parameters (i.e., muscle Kp 
and RBCu) that are difficult to obtain and not regularly measured. The Vss in rats is a readily 
available parameter; therefore, PK studies in rats are completed relatively early in the drug 
discovery process and are commonly completed for environmental xenobiotics 
[18]
. The current 
study aims to develop a correlation-based Kp prediction model that directly uses the rat Vss as a 
primary Kp predictor and links this value with secondary physicochemical parameters for tissue-





Drug specific parameters  
The drug-specific parameters that affect the tissue distribution are the lipophilicity, the degree of 
ionization, and the plasma protein binding.  In this model, the distribution of a drug into and out 
of a tissue was solely attributed to passive diffusion.  
The lipophilicity of a drug, which is one of the most important ADME-related properties, has a 
major effect on its pharmacokinetics. The lipophilic or hydrophilic properties of a drug can be 
described by the N-octanol-water partition coefficient (LogP). N-octanol is considered to imitate 
the hydro-lipophilicity balance of biological membranes because it contains a saturated alkyl 
chain and a hydroxyl group and has a similar solubility in water 
[29,35]
.  In general, a high lipid 
solubility leads to a high affinity to neutral lipids, proteins and other macromolecules, which 
ultimately imparts extensive drug distribution 
[36]
. LogP values were incorporated into the 
statistical analysis to account for a drug’s affinity to the lipophilic constituents of a tissue.  
 





















The tissue distribution is greatly affected by the acidic/basic properties of the compound. It is 
hypothesized that an electrostatic interaction between the cellular acidic phosphatidylserine and 
the basic moiety of a drug is crucial to the definition of the tissue distribution of moderately to 
strongly basic drugs 
[7,8,44]
. However, acidic, weakly basic and neutral compounds are known to 
bind to extracellular proteins: acids and weak bases bind to albumin and lipophilic neutrals bind 
to lipoproteins (Rodgers & Rowland 2006). These classes of compounds tend to have smaller 
distribution volumes than moderate to strong bases 
[9,45]
. As a result, compounds were considered 
in two groups: moderate to strong bases and acidic, neutral and weak bases (see below).  
The degree of ionization is an important factor in tissue distribution. This is mainly due to the 
differential pH between the plasma/interstitial space and the intracellular water space. As shown 
in table 2-1, the pH of tissues is lower than the plasma pH (7.4) and varies across the tissue. 
Therefore, the influence of the degree of ionization on the distribution is different for each tissue. 
To account for the inter-tissue distribution variation, the ionized fraction of the drug (fi) was 
calculated (Eqn 2-3 to 2-7); these values represent the degree of ionization at a tissue-specific 
physiological pH: 
Eqn. 2-3 
1]101[1  tissuepHpKafi  for monoprotic bases, 
Eqn. 2-4




fi  for diprotic bases, 
Eqn. 2-5
1]10[1  pKatissuepHfi   for monoprotic acids, 
Eqn. 2-6










fi for zwitterions. 
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The tissue-specific fi values of each compound were incorporated into the statistical analysis as 
potential predictor variables.  
The steady-state concentration of an unbound drug is equal in all of the body tissues, regardless 
of the degree of the binding to macromolecules 
[46]
. Therefore, the value of Kp can be defined as 
the ratio of the fraction of unbound drug in the plasma to the fraction of unbound drug in the 
tissue.  The unbound fraction in the plasma (fup) was therefore incorporated into the statistical 
analysis as a potential predictor of Kp. 
 
Data collection  
A database of the experimentally derived Kp values, the rat Vss and the corresponding 
physicochemical properties was created from the literature (Appendix 1-4). Additional criteria 
for the inclusion of data into the study were: (i) the reported Kp values plausibly represent the 
true steady-state distribution or the pseudo equilibrium and (ii) the Vss and fup values in rats were 
available. It was assumed that all organs were non-eliminating such that the experimental and 
predicted Kp values were not affected by extraction ratio. The stereoselectivity was also 
considered; thus, the R and S enantiomers were regarded separately. In addition, experimentally 
determined LogP and pKa values were preferably used; if these were not available, calculated 
values were used 
[46,47]
. As has been observed previously, the correlation between calculated and 
experimentally determined values is in good agreement 
[5]
. When the tissue-to-plasma water 
(Kpu) parameter is reported, as in Rodgers et al., 
[8,9]
 the associated Kp was obtained by 
multiplying the values of fup and Kpu. If more than one experimental tissue Kp value was 




Regression model development  
A stepwise multiple linear regression analysis using R (i.e. language and environment for 
statistical computing) 
[48]
 was employed to develop a tissue-specific Kp prediction algorithm 
based on Vss, LogP, the degree of ionization and fup. The important drug-specific parameters in 
the tissue distribution were incorporated to account for inter-tissue variation with the resulting 
structure:  
Eqn. 2-8 443322110 xxxxLogKptissue    
Where β0, β1, β2, β3, β4 are coefficients and x1, x2, x3, x4 are Log Vss, LogP, fup, fi, respectively.     
Eqn. 2-8 is the largest model considered for each model. Smaller models were considered 
through stepwise regression. At each step of the stepwise regression analysis, a variable was 
either added or removed. The process was stopped when the fit yielded the greatest reduction in 
the Akaike information criterion (AIC) statistic 
[49]
. The best regression equation for a tissue was 
determined such that it satisfied all of the selection criteria: (i) the equation resulted in the 
smallest AIC value in the analysis, (ii) the equation had the smallest sum of squared residuals, 
and (iii) the inclusion of a variable and the sign of its coefficient were reasonable (discussed 
below). In addition, to detect if the predictor variables were linearly related (i.e., the 
multicollinearity issue), the variance inflation factor (VIF) for each equation was screened. The 
VIF indicates the increase in the variance due to collinearity. A VIF value of 5 was used as the 
cut-off criterion 
[19,50]
. If a multicollinearity problem was deemed to be present (i.e., VIF > 5), a 
given predictor was deleted and the next best equation was sought based on the AIC statistics. 
The dataset was divided into two subsets. Subset A was comprised of moderate to strong bases 
(pKa ≥ 7.4). Subset B consisted of acidic and neutral compounds, zwitterions, and weak bases 
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(pKa ≤ 7.4). For each tissue and each subset, the collected data was randomly divided such that 
80% was used as the development set and 20% was used as the test set. 
 
Evaluation of the obtained regression equations  
The predicted Kp values (Pred) were plotted against the observed Kp values (Obs) for the test 
datasets of Subset A and Subset B.  The adjusted coefficient of determination (Adjusted R
2
) was 
used as a measure of the percentage of Kp variability that was explained by the predictor 
variables 
[50]
. This measure represents the goodness of fit of each obtained equation. The 
precision of the obtained equation was assessed using the root mean square error (RMSE) (Eqn. 










Comparison of the accuracy of the model with the accuracy of the models developed by Jansson 
et al. and Rodgers et al. 
Using the Subset A and Subset B test datasets, the accuracy of the algorithm was compared 
against the accuracy of an existing correlation-based 
[5]
 and a TCB model 
[8,9]
, both of which 
have been found to be good Kp predictors compared to other published algorithms 
[33,34]
. The 
relative prediction accuracy was measured by calculating the percentage of predicted Kp values 
that exhibited a less than two-fold error deviation from the experimental data. 
For each of the three algorithms, a measure of bias, the average fold error (AFE), was calculated 
(Eqn. 2-10). The AFE indicates an under-prediction (AFE < 1) or an over-prediction (AFE > 1) 
compared to the observed values. The absolute average fold error (AAFE) quantifies the overall 
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magnitude of the deviation between the predicted and the observed Kp values (Eqn. 2-11). To 
rank the overall precision of the model, the root mean squared error (RMSE) was calculated 


























































AAFE    
 
2.4 Results 
Development and prediction accuracy of the algorithm  
The Kp prediction equations for moderate to strong bases (Table 2-2) and acids, neutrals and 
weak bases (Table 2-3) demonstrated a positive association between the Vss and the observed Kp 
values (Figure 2-1). The Vss parameter was used as a primary predictor of all tissue Kp values. 
The incorporation of LogP significantly improved the correlation between the tissue Kp values 
and the Vss for the adipose and lung tissues. The fup was a key factor in the muscle Kp prediction 
(Tables 2-2 and 2-3). In the analysis of the heart, lung and muscle, the degree of ionization was 
an important predictor for all classes of compounds. No single equation displayed 
multicollinearity; thus, all of the VIF values were less than 5. For moderate to strong bases 
(Subset A), the degree of ionization had a positive effect on the Kp, whereas it had a negative 




Table 2-2.  Correlations between the experimentally derived rat Kp values, the Vss and the 
physicochemical parameters for strong to moderate bases (Training Set A)   
Tissue n Regression parameters Adjusted R2 RMSE 
Intercept LogVss LogP Fi fup 
Adipose 33 -0.800 0.500 0.241 - - 0.66 0.299 
Bone 24 -2.157 0.86 - 2.122 - 0.68 0.263 
Brain 47 -0.406 0.804 0.071 - - 0.37 0.499 
Gut 27 -5.191 0.711 - 5.672 0.275 0.68 0.236 
Heart 50 -1.514 0.850 - 1.648 - 0.84 0.169 
Kidney 54 0.405 0.861 - - 0.309 0.53 0.308 
Liver 52 0.392 1.035 - - - 0.48 0.415 
Lung 51 -5.585 0.933 0.201 5.726  0.80 0.289 
Muscle 53 -2.074 0.707 0.056 1.902 0.318 0.75 0.191 
Spleen 9 0.066 1.041 - - - 0.84 0.159 
Skin 28 -0.144 0.663 0.033 - - 0.80 0.122 
R
2
, coefficient of determination; RMSE, root mean square error  
 
Table 2-3. Correlations between the experimentally determined Kp values, the Vss and the 
physicochemical parameters for acids, weak bases and neutral compounds (Training Set B). 
Tissue n Regression parameters Adjusted R2 RMSE 
Intercept LogVss LogP Fi fup 
Adipose 21 -0.298 1.144 0.231 - - 0.64 0.374 
Bone 13 -0.245 0.984 -  0.42 0.87 0.142 
Brain 31 0.085 0.605 - -0.832 - 0.67 0.302 
Gut 26 0.043 0.831 0.067 - - 0.62 0.238 
Heart 35 0.146 0.644 - -0.308 - 0.75 0.215 
Kidney 31 0.463 0.425 - -0.316 - 0.39 0.277 
Liver 33 0.376 0.726 0.074 -0.333 - 0.79 0.237 
Lung 32 -0.434 0.693 0.185 -0.286 0.520 0.83 0.222 
Muscle 38 -0.122 0.65 - -0.431 0.269 0.7 0.249 
 
 27 
Spleen 18 0.136 1.008 - -0.26 - 0.77 0.241 
Skin 26 -0.331 0.544 0.158 -0.318 0.384 0.73 0.186 
R
2
, coefficient of determination; RMSE, root mean square error  
 
Using the test datasets (Table 2-4), the calculated Kp values were in good agreement with the 
experimentally determined Kp values. Sixty-seven and sixty-two percent of the predicted Kp 
values fell within a two-fold deviation error of the experimental Kp values for Subset A and 
Subset B, respectively (Figure 2-2), which demonstrates similar relative prediction accuracy.  
Based on the RMSE values, the equations for moderate to strong bases had better precision 











Figure 2-1. Association between Vss and observed Kp values for (a) moderate to strong bases and for (b) acids, neutral compounds, and weak 









Figure 2-2. Logarithmic plot of observed vs. predicted Kp values for (a) moderate to strong bases (test set A) and for (b) acids, weak bases and 
neutral compounds (test set B).  A total of 20 compounds and 154 tissue-specific Kp values are represented. The solid lines represent the ± 2-fold 
deviation from the experimental data.  
Vss





































































































Comparison of the Kp prediction accuracy of the proposed algorithm with the accuracy of 
published algorithms 
The Kp values for the Subset A and B test datasets were predicted using the algorithms presented 
in this study as well as with the algorithms developed by Jansson et al. 
[5]
 and Rodgers et al. 
[8,9]
.  
In terms of the overall prediction performance, the proposed model had greater predictive 
performance with lower RMSE values, AFE values closer to 1 and the greatest percentage of 
values within a 2- to 3-fold deviation error from the experimental values (Table 2-4). The 
prediction accuracy of the algorithms was tissue-dependent (Figure 2-3). For both Subsets, the 
presented algorithm had better prediction accuracy for the brain, kidney, liver, muscle and spleen 
Kp values. The adipose Kp values obtained with the proposed algorithm were under-predicted 
and had a poorer predictive accuracy compared to published algorithms. In addition, all 
algorithms resulted in a poor prediction of both the heart and the muscle Kp values for 
phencyclidine and FTY-720 in Subset A (see outliers in Figure 2-3). 
Table 2-4. Accuracy of the Kp prediction obtained using the proposed algorithm and previously published 
models for the test datasets A and B 
[5,8,9]
 
 Model n AFE AAFE 
% within  2-fold of 
the experimental data 
% within  3- fold of 
the experimental data 
RMSE 
Test set A 














77 1.69 3.37 29% 51% 0.61 
















77 1.49 3.40 53% 59% 0.72 





















Figure 2-3. Box and Whisker plot of the logarithm of the ratio between the predicted and observed Kp 
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This study proposed a correlation-based Kp prediction algorithm that was built using a total of 96 
compounds and 723 tissue Kp values. The relationships between the experimentally determined 
Vss and the tissue Kp parameters, in addition to the physicochemical properties of the 
investigated drug, were used to derive the relevant Kp prediction equations. The algorithm differs 
from other correlation-based prediction algorithms due to its direct use of Vss as a primary 
predictor variable and its use of the unbound fraction of the drug in the plasma and the degree of 
ionization as secondary predictor variables. 
Our approach directly uses Vss as a Kp predictor variable, whereas Jansson et al. 
[5]
 used the 
muscle Kp as a main predictor. In Jansson et al.
[5]
, the muscle Kp can be derived from the Vss; 
this derivation, however, can potentially cause great uncertainty in the estimated value of the 
muscle Kp. When the experimental muscle Kp value is used as an input in Jansson et al.’s model 
[5]
, a better prediction performance was observed (data were not shown in present study). 
However, the value of the muscle Kp is not likely to be available, which limits the use of Jansson 
et al.’s model 
[5]
. By using the positive relationship between the tissue Kp values, an in vivo 
parameter (i.e., Vss) and physicochemical descriptors (i.e., LogP, fup, and the degree of 
ionization), our method had better prediction accuracy than Jansson et al.’s model 
[5]
.  
Moderate to strong bases often have large volumes of distribution with significant inter-organ 
variation 
[44]
. One of the contributing factors to this variation is the uneven pH difference 
between the plasma and the tissues. Basic drugs tend to be stored in tissues with a pH that is 
lower than their pKa values. Due to the lower pH in the tissues, there would be a greater fraction 
of ionized species than unionized species and the positively charged ionized fraction would 
electrostatically interact with the negatively charged cell constituents. Even small differences in 
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the pH between the matrices and the plasma, which has a pH of 7.4, and tissues with a lower pH, 
such as the lung (pH 6.6), muscle (pH 6.81) and kidney (pH 7.22) (Table 2-1), are likely to 
create a large pH gradient that would result in the accumulation of a basic drug in a tissue 
[6]
. The 
electrostatic interaction of the ionized fraction with acidic phospholipids, such as 
phosphatidylserine, phosphatidylinositol, phosphatidylglycerol and phosphatidic acid 
[8]
, is a 
crucial factor in the inter-organ variability of the tissue distribution 
[14]
. There is a positive 
relationship between the Kp values and the concentration of acidic phosphatidylserine for 
moderate to strong bases that contain amines 
[44]
. In addition, tissues vary in their acidic 
phospholipid composition. Thus, due to its inclusion as a predictor variable, the degree of 
ionization was expected to have a positive effect on the tissue partitioning for moderate to strong 
bases, which was indeed demonstrated in the resulting regression equations. The poor Kp 
prediction for some basic drugs can be explained by ion trapping. Basic drugs tend to be 
concentrated in lysosomes due to ion-trapping and/or intracellular binding. Unionized bases 
penetrate membranes and localize to acidic environments in cells, such as lysosomes. In an 
acidic organelle, bases become protonated and are thus unable to diffuse to the cytosol 
[51]
. This 
behavior is an important factor in the drug distribution in lysosome-rich tissues, such as the liver, 
lung and kidneys 
[52]
. Ion-trapping is the primary driving factor in the intracellular retention of 
hydrophilic strong bases, whereas ion-trapping and intracellular binding are equally important in 
the intracellular retention of polar strong basic drugs with high lipophilicity (e.g., propranolol) 
[52]
. One of the outliers in our study was imipramine; there is a clear deviation between the 
observed and the calculated Kp values of this drug in the liver, lung, and kidney.  Lysosomal 





the tissue pH that was used in the calculation of the degree of ionization was that of the whole 
tissue and not that of the individual organelles, this deviation is reasonable.  
Neutral compounds, acids and weak bases (pKa ≤ 7) are likely to behave similarly to each other. 
In the plasma and tissues, these compounds primarily exist in their neutral form and only a small 
portion of these are ionized. In addition, hydrophobic interactions between the neutral 
components of a cell and reversible binding to extracellular proteins are expected to be prevalent 
with these compounds 
[8,9]
. The level of tissue partitioning of weak bases is generally similar 
across the body and independent of the concentration of phosphatidylserine in the tissues 
[44]
. 
The accumulation of acidic drugs, however, is a function of the differential pH between the 
plasma and the different tissues.  The high degree of ionization of acidic drugs in the plasma 
would limit their entry into cells; in addition, once inside a cell, the acidic phosphatidylserine 
would have repulsive electrostatic interactions with the ionized fraction of these acidic drugs 
[6]
. 
As a result, acidic drugs tend to accumulate to a greater extent in tissues with a higher pH 
because the unionized fraction in these tissues is greater than in tissues with a lower pH. Our 
study demonstrated that the Kp values of acidic drugs are negatively correlated with the degree of 
ionization (Table 2-3). 
In general, the fup and Vss parameters have a positive relationship. However, an increase in fup 
does not yield a proportional increase in Vss, especially when a drug is found to be mostly bound 
to proteins 
[46]
. This result indicates that the protein binding information is an important factor 
that should be utilized in the estimation of the tissue distribution of these drugs. Thus, fup 
provides information on distribution patterns that Vss alone cannot convey. Despite the 
association of these variables, no mathematical evidence of collinearity was found in the 
construction of the prediction equations.  
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The prediction of the brain Kp is considered to be a challenge due to the blood brain barrier 
(BBB), which prevents many molecules from penetrating into the brain 
[8,54]
. Tight junctions 
between the endothelial capillary and the glial processes near the capillaries make the BBB 
impermeable to polar molecules 
[55]
. In general, lipophilicity has a positive effect on the drug 
partitioning to the brain because only lipophilic drugs can be transported through the BBB by 
simple diffusion. However, if the drug is a substrate of p-glycoprotein (Pgp), the resultant poor 
permeability of these lipophilic drugs may be the result of the efflux function of Pgp. Thus, the 
observed brain Kps for Pgp substrates would account for additional processes, such as the rate of 
drug partitioning either by passive diffusion or by active transport, the rate of drugs that are 
repelled back to the blood by Pgp, and the non-specific binding to the BBB 
[56]
. The presented 
approach assumes that the tissue partitioning is driven by the passive transport of a molecule into 
tissues, even though one group of researchers has questioned the validity of assuming passive 
diffusion for any drug 
[57]
.  The input Kp for a PBPK model is the Kp that assumes passive 
diffusion since active processes affecting permeability are accounted for separately. However, 
for algorithm development, the lack of consideration of active processes in the development 
datasets may have led to the poor prediction accuracy that was observed with the brain Kp 
(Figure 2-3).  Although a poor brain Kp prediction with a relatively large standard deviation was 
obtained, the presented algorithm resulted in a better prediction of this parameter than other 
models. 
An under-prediction was observed with the adipose Kp values for both test datasets. A poor 
prediction of the adipose tissue was also reported in the previous Kp estimation studies that used 
a correlation-based approach 
[4,5,7]
. The possible reason for this decreased accuracy in the adipose 
Kp prediction is the different lipid composition of this tissue compared to other tissues. In 
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adipose tissue, neutral lipids are more abundant than other cell constituents, such as 
phosphatidylserine, and other lipids 
[7,8,29]
. Therefore, in these cases, the hydrophobic interactions 
are more dominant than the electrostatic interactions, thereby leading to the accumulation of 
lipophilic drugs in adipose tissues. Jansson et al. 
[5]
 stated that the adipose Kp, prediction from 
the muscle Kp was less accurate compared to other tissues. Poulin and Theil presented a different 
approach that used an adjusted skin Kpu to estimate the adipose Kpu 
[7]
. It has been suggested that 
the variation in the adipose tissue Kp among the different classes of drugs cannot be simply 
explained by the physicochemical and in vivo parameters. Therefore, a different approach is 
required to increase the prediction accuracy of the adipose Kp. Another contributing factor in the 
poor prediction of the adipose Kp may be the inaccuracy of the LogP values and to the inter-
laboratory variation that exists in the determination of these parameters 
[5]
. Thus, this result 
highlights the importance of using accurate physicochemical information for the prediction of 
Kp. 
Phencyclidine is a cationic-amphiphilic drug that acts mainly on the inotropic glutamate 
receptors in the rat brain 
[58]
. All three algorithms resulted in a poor Kp prediction for this drug, 
especially in the muscle and heart (shown in Figure 2-3 as an outlier). The other outlier for heart 
Kp was FTY-720, which is a therapeutic drug used for the treatment of heart failure through the 
activation of Pak1 signaling 
[59]
. Both of these drugs are highly lipophilic with LogP values 
greater than 4.00 and are highly ionized at physiological pH. Because the values of some inputs, 
such as LogP and Vss, were large, the algorithms yielded larger Kp values compared to the 
experimentally determined Kp. There is no current explanation for these results since other 
tissues within each compound were adequately described. A possible explanation is the presence 
of an efflux transporter in those affected tissues that was not considered. 
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Correlation-based models, unlike TCB models, are dependent on the dataset that is used in their 
derivation. The mechanistic equations are potentially applicable for any species if the tissue-
specific physiological parameters are available. Parameterizing TCB models requires less in 
vivo/ex vivo (e.g., fup) information than correlation-based models, which require muscle Kp, Vss 
or RBCu. TCB models require complex parameterization. Many researchers have strived to 
develop prediction algorithms using complex parameters to describe the distribution process at a 
cellular level within a mechanistic structure. Some Kp prediction algorithms require many input 
parameters, such as the blood-to-plasma ratio, red blood cell partitioning data, and the 
phosphatidylcholine-to-water partition coefficient at pH 7.4 
[6-8]
, that may be unavailable. 
Furthermore, some TCB algorithms are mathematically heavy and their reproduction is difficult.  
However, correlation-based models rely on the dataset 
[8]
.  If the dataset used is small, the data 
pool may not represent an accurate sampling and the fit is thus likely to be sensitive to the 
inclusion/exclusion of an observation. The input parameters (e.g., muscle Kp 
[4,5,7]





, and RBCu 
[7]
) are often not easily obtained, which limits the ability to make a 
priori predictions. The proposed algorithm was derived using a larger dataset than all previously 
developed correlation-based algorithms.  
2.6 Conclusion 
The derived Kp prediction algorithm is mathematically simple and employs input parameters 
generally available in pre-clinical drug development or early toxicological assessment. In 
addition, the model has greater prediction accuracy in comparison to the best correlation-based 







Development of a decision tree to classify the most accurate tissue to plasma 
partition coefficient algorithm for a given compound in rats 
 
3.1 Introduction 
Partitioning of a compound into a tissue is a complex process. In PBPK modeling, the estimation 
of a compound’s distribution parameters has limited the accessibility of this modeling technique 
due to difficulties in their experimental determination (i.e. Kps) in the species of interest 
[28]
. In 
order to overcome this barrier, numerous in silico methods for Kp prediction have been 
developed 
[2,4-9,12,13,16]
. Despite increasing attention and interest in the accurate prediction of 
compound distribution data or tissue dosimetry profiles, a standard Kp prediction method has not 
yet been determined. There is no single prediction algorithm that is applicable for all compounds 
in all tissues (see Table 3-1). The accuracy of the pre-existing Kp prediction algorithms still 
require improvement 
[6]
. The predictability of any single Kp prediction algorithm, whether it is a 
tissue composition based or a correlation based algorithm may vary depending on the physico-
chemical properties of a compound and/or the physiological parameters of an organism. These 
algorithms may also have varying tissue specific prediction accuracies. Furthermore, the 
experimental determination of all of the required compound specific chemical descriptors and in 
vitro and in vivo input parameters can limit the use of some Kp prediction algorithms. In other 
words, the availability of these parameters often determines the usability of an algorithm. For 
these parameters, estimation equations are suggested as an alternative to experimental 
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determination. Therefore, the estimation equations will allow use of Kp prediction algorithms 
with a minimal number of readily available compound specific parameters. With the use of 
estimation equations, this study aims to determine the best performing algorithm in a specific 
physico-chemical space for a single tissue. In order to address this problem, statistical 
classification techniques are used.   
 
Machine learning methods for decision tree development   
Machine learning refers to the construction of a system that can learn from training data. 
Learning algorithms for classification learn based on certain data (e.g. measurement data or 
categorical data) and a response of interest 
[60]
. The objective of machine learning is to 
characterize the observed phenomenon and generalize it (i.e. inductive inference), in an attempt 
to make accurate predictions for a new sample 
[60]
. Decision tree learning is a decision support 
system that uses a tree-like model of decisions. The decision tree based classification methods 
were investigated to identify the best performing algorithm in a specific physico-chemical space 
for each tissue.  
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Table 3-1. Summary of applicability of Kp prediction algorithms  
 Algorithms Acid Base Neutral Zwitterion Adipose Bone Brain Gut Heart Kidney Liver Lung Muscle Pancreas Skin Spleen Testes Thymus RBC 
1 Bjorkman [4] v v   v v v v v v v v   v     
2 Berezhkovskiy [12] v v v v v v v v v  v v v  v     
3 Rodgers et al [8]  v   v v v v v v v v v v v v  v  
 Rodgers & Rowland [9] v  v v v v v v v v v v v v v v  v v 
4 Schmitt [6] v v v v v v v v v v v v v v v v v  v 
5 Jansson et al [5] v v v v v v v v v v v v v  v     
6 Poulin &Theil [7]  v   v v v v v v v v v  v v  v  
7 Yun and Edginton [19] v v v v v v v v v v v v v  v v    
8 The proposed study v v v v v v v v v v v v v  v v    
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Recursive partitioning method  
The recursive partitioning method creates a decision tree that aims to correctly categorize 
members of groups based on several variables 
[61]
. The variables in this analysis are not assumed 
to follow any specific statistical distribution. A classification tree is represented as an inverted 
tree with a root node at the top, branches connecting nodes and leaves at the bottom 
[50]
. The 
schematic below presents an example of an output of the recursive partitioning method. At each 
node, a question regarding a variable is posed. The leaves denote classifications (i.e. a Kp 
prediction algorithm) and the child nodes represent splits that lead to the classifications. The 
numbers at the end of a leaf (Figure 3-1) depict the number of cases within a test dataset that 
were best represented by different categories or Kp prediction algorithms. For the leaf in Figure 
3-1, the classification is category 2 because it has the highest frequency in the leaf (Figure 3-1). 
 
 Figure 3-1. An example of a classification tree developed using recursive partitioning. The left tree is 




The classification tree is built using the following steps. A variable (e.g. LogP) that best splits 
the data into two groups is based on the criterion of the Gini index (Eqn. 3-1). Let I(A) be an 
impurity function of a node A.  
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where pk is the fraction of samples in a node A that belong to class k (k=1,2,…K). The 
probabilities (i.e. pk,, pj)  are calculated from node frequency (e.g. Figure 3-1 - 7/18/2).  A split is 
chosen when the split results in maximal impurity reduction. At each possible split, the sample is 
divided into child nodes 
[62]
. The data is subdivided repeatedly until there is no reduction in 
impurity of a node is possible. If a case with the response “true” to the question posed, it is sent 
to the left child node and the “no” responses are sent to the right child node.  
The schematic (Figure 3-1) shows an example of a pruning process of the recursive partitioning 
method. Large trees use a larger number of variables, and these trees may result in overfitting of 
the data. In order to avoid this, a cost-complexity pruning is performed to extract insignificant 
splits 
[63]
. The aim of the tree pruning is to identify a nested version (i.e. subtree) of a fully grown 
tree so that the nested tree minimizes the measure of cost-complexity on an independent test set 
[63]
. The cost-complexity measure can be expressed as following: 
Eqn. 3-2 TtRTR   )()(  
where Rα(T) is the misclassification cost of the whole tree at a complexity parameter α,  and R(t) 
is the misclassification cost evaluated at the node. The number of nodes is denoted as | |. A 
complexity parameter α (α > 0), which penalizes cost, is assigned a one unit increase in 





The sum of all misclassification costs is converted into a penalty for the complexity of the tree. 
The complexity of the tree increases as the number of nodes (i.e. size of the tree) increase 
because the data is further divided into the smaller parts. The complexity parameter α adjusts for 
the influence of tree size on cost-complexity. If α = 0, the largest tree will be chosen. If α 
approaches infinity, then a root node without any child node will be selected (| | = 1).  
 Due to the absence of an independent test set in most cases, cross validation is used as an 
alternative to external validation. Recursive partitioning is implemented in the rpart package in 
R and by default, the rpart function in rpart package performs 10 fold cross validation 
[48,64,65]
. In 
this procedure, the dataset is divided into 10 equally sized segments. Nine segments are used for 
growing a classification tree and the tenth segment is used as a test set. To obtain the optimal 
tree, the complexity parameter that minimizes the 10 fold cross validation error is selected.  
 The function prune() in the rpart package 
[48,65]
 trims the tree to the complexity parameter value 
that minimizes cross validation error 
[64]
. For the left tree in Figure 3-1, according to complexity 
parameter, it is found that a tree with 4 splits had a lower cross validation error as compared to a 
tree with 5 splits. As a result, the last split was extracted. 
 
Random forest and bootstrap aggregation 
Random forest and bootstrap aggregation (Bagging) are also methods of classification. These 
methods are based on a collection of classification trees instead of a single tree, as in recursive 
partitioning. These methods generate multiple versions of a classification tree by using 
bootstrapping, and aggregate the classification from the various trees. Bootstrapping 
[66]
 is a 
procedure inherent in both random forest and Bagging. This procedure determines the reliability 





. If the dataset set follows the assumption of independent and identically 
distributed observations, a bootstrap sample is drawn with the same sample size as the original 
dataset with replacement. 
- Random forest  
A random forest is defined as a classifier that is comprised of a set of classification trees  
Eqn. 3-3  Nkxh k ,.....1),,(   
where x is an input vector (i.e. explanatory variables) and the (Θk) are the independent 
identically distributed random vectors 
[67]
.  N bootstrap samples are drawn from the training data. 
For each bootstrap sample, the number of input parameters, mtry (mtry=1,2,…M), are randomly 
chosen (mtry << M) and a classification tree is grown in the same way as recursive partitioning. 
In other words, each tree is created using a random set of samples and input parameters.  
At each node of a tree, the variable that results in the greatest decrease in impurity is selected to 
separate the child nodes. Much like in recursive partitioning, the impurity of the node is 
measured by the Gini index (Eqn. 3-1). The splitting continues until the child node has only 
samples that belong to the same class.  
Each tree is grown without pruning, in that the tree is grown to its largest extent and the tree size 
is not optimized. The random selection of variables results in trees with minimal correlation to 
each other. In order to classify an object from input x (Eqn. 3-3), the object (xnew) is put to each of 
the trees grown in the forest, and consequently, each tree classifies it to a group. With a new 
input xnew, each tree results in a classification. Among unpruned trees (e.g. by default ntree = 500), 
the classification with the most votes is selected by the forest. For each tree, about 67% of the 
data is drawn from an original dataset to create a tree by recursive partitioning, as described 





bootstrap samples are drawn with replacement, about 36 % of the total data is OOB on average 
[69]
.  
Each classification tree created from a training set makes predictions for the OOB sample at each 
iteration. From the aggregated OOB predictions, the OOB estimate of error rate is calculated. 
[69]
 
This internal estimate of error rate tends to overestimate the error that a tree grown from the total 
dataset would. However, it does allow for an assessment of the classification performance of a 
random forest. Via a built-in cross validation function of rfcv() in the randomForest package in 
R 
[48,69]




- Bootstrap aggregation  
In the Bagging method 
[71]
,  a set of classification trees are grown. A training data α is comprised 
of {(yi, xi), i=1…I} where y is class and x is input vector. A classification tree from the training 
dataset can be expressed as φ(x, α). N bootstrap samples αk (k=1….N), is drawn from a training 
set α at random, but with replacement. A decision tree without pruning is grown based on each 
bootstrap sample using recursive partitioning. However, unlike the random forest method 
described above, all variables are considered as a potential split for each tree (mtry=M) 
[71]
.  Due 
to random variation inherent in bootstrapping, each tree differs from one another.  A set of  
classification trees φ(x, αk) is aggregated by the majority vote as the same principle of majority 
vote in the random forest method 
[69,72]
. Both random forest and bagging methods exploit the fact 
that a single classification tree is very unstable and that a small change in the training set can 
result in different classification. But, the aggregation of multiple versions of the classification 





3.2 Objectives and Hypothesis 
 The current study aims to develop a decision tree that will choose the most accurate algorithm 
for the prediction of tissue specific Kps. This study employed a classifier learning algorithm to 
develop a classification tree that will identify the most precise algorithm for a compound within 
a given physico-chemical space. The objectives of the predictive classifier are: (i) to provide Kp 
predictions using readily available parameters and (ii) to use the most accurate prediction 
algorithm to calculate tissue-specific Kps for a compound. It is hypothesized that the developed 
classification tree(s) will produce a more accurate overall prediction of Kps than any one Kp 
prediction algorithm alone.  
3.3 Methodology 
Data collection  
A database of experimentally derived partition coefficients with corresponding compound 
physico-chemical properties were created from the literature using several MEDLINE searches. 
In vivo parameters such as the fraction unbound in plasma (fup) and volume of distribution (Vss) 
were also included in the database. Data was included in the study based on the following 
criteria: (i) reported Kp values plausibly represent true steady state distribution/ pseudo 
equilibrium and (ii) fup, pKa, and one of the lipophilicity measures (i.e. LogP, LogD, 
LogKvo:w) were available. When experimental physicochemical parameters (e.g. all 
lipophilicity measures, pKa) were not available in the literature, the values were obtained from 
predictions made in ChemEbl 
[47]
. Experimentally determined values were preferably used over 
predicted values. Stereoselectivity of a compound was considered, if applicable, so that R and S 
enantiomers were considered separately. As shown in Table 3-1, decision trees for pancreas, 
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testes, thymus and RBC were not generated since the number of data points was insufficient for a 
classification analysis.   
 
Estimation of required inputs 
Table 3-2 presents the required input parameters for each algorithm. In the event that a required 
input parameter was not available, it was calculated based on regression equations presented in 
Table 3-3. For example, if only LogP was available but LogD was the necessary input parameter, 
LogD was calculated using equations based on the equations derived by Poulin et al 
[15]
 (see 
Table 3-3). For some input parameters [e.g. LogMA, LogHSA, and blood: plasma ratio (B:P)], a 
regression equation was derived using the datasets in the Rodger et al. 
[8]




 Affinity for blood cells (KpuBC)  (i.e. unbound compound concentration in blood cells) is one of 
the required parameters for the Rodgers et al. 
[8,9]
 algorithms. KpuBC is the function of fup, B:P 
and hematocrit. KpuBC is estimated using the standard equation (Eqn. 3-10) in the Rodgers 
models 
[8,73]
. In the absence of an observed B:P, B:P is estimated using the estimation equation 
(Eqn. 3-11) proposed by Paixao et al. 2009 
[74]
. This equation was derived from Rodgers et al. 
2006. The assumptions for the equations are that: (i) in erythrocytes, there is no extracellular 
space and (ii) albumin and lipoproteins are not contained within the space.  
While the first approach to B:P estimation was the use of a mechanistic model as descried above, 
another approach was also taken for B:P estimation. This was the development of a regression 
equation (Eqn. 3-12). Experimentally determined B:P, LogP and fup (n = 28) were obtained from 
Rodgers et al. 
[8]
 and a predictive regression equation was developed based on the dataset. For 
the linear regression analysis, the statistical software R version 2.12 
[48]
 was used. The estimation 
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equation that yielded a more accurate Kpu prediction when compared to the observed Kpu values 
was selected for the calculation of Kps for Rodgers et al. 
[8,9]
 in this study.  
For the calculation according to Schmitt’s algorithm 
[6]
, the logarithmic value of 
phosphatidylcholine: water partition coefficient at pH 7.4 (LogMA) and the logarithmic value of 
human serum albumin (LogHSA) must be estimated in the absence of the experimentally 
determined values. Using the dataset provided by Schmitt, LogP, LogMA, and LogHSA (n =60 
data points) were obtained. The regression equations for LogMA (Eqn. 3-8) and LogHSA (Eqn. 
3-9) were generated.   
 
Table 3-2. Summary of Kp prediction algorithm and their main inputs.   
Algorithm Approach Main inputs 
Bjorkman 
[4]
 Correlation based Muscle Kp 
Berezhkovskiy 
[12,16,29]
 Tissue composition based LogP, LogKvo:w, fup 
Rodgers et al.  
[8,9]
 Tissue composition based LogP, pKa, fup, B:P 
Schmitt 
[6]
 Tissue composition based LogP, LogD, LogKvo:w, LogMA, LogHSA, pKa, fup 
Jansson et al. [5] Correlation based Vss, Muscle Kp, LogP, LogD, LogKvo:w 
Poulin and Theil 
[7]
 Correlation based Muscle Kp or RBCu 
Yun and Edginton 
[19]





Table 3-3. Summary of equations used to estimate an unknown input parameter. 
 Parameter Description Equation Reference 
Eqn. 3-4 Fut_lean tissue Fraction of unbound 





Eqn. 3-5 Fut_adipose 
tissue 
Fraction of unbound 





Eqn. 3-6 LogD  Partition coefficient of 
octanol and water at specific 
pH  
Monoprotic base 
)10+Log(1-LogP 7.4-pKa1  
Diprotic base  
)10+10+Log(1-LogP 7.42pKa2-+pKa17.4-pKa1   
Monoprotic acid 
)10+Log(1-LogP pKa17.4-  
Diprotic acid  
)10+10+Log(1-LogP pKa2-pKa17.4-2pKa17.4-   
Zwitterions 
)10+10+Log(1-LogP pKa_acid7.4-7.4-pKa_base  








LogKvo:w Logarithmic value of 
partition coefficient between 







LogMA  Logarithmic value of 
membrane affinity.  
LogMA =1.294+0.304*LogP 
This equation was obtained using Schmitt’s dataset. In the dataset, 
there were 60 logMA values available. The regression equation was 









This equation was obtained using Schmitt’s dataset. In the dataset, 
there were 60 logHSA values available. The regression equation was 
developed and was statistically significant (P<0.05). 
[6]
 
Eqn. 3-10 Kpu_BC  
(Affinity for 
blood cell)  
Red blood cell to plasma 
partition coefficient of 
unbound compound, 
Affinity of a compound for 










































Blood to plasma 
ratio(B:P) 
 Log(B:P) = -0.004282 +0.067028 LogP + 0.214590 Log(fup)  
 (n=28 , R
2
=0.40 )  
This equation was obtained using Rodgers et al. 
[8]
 dataset. In the 
dataset, there were 28 experimentally determined BP values available. 












, 10  
[5]
 
Eqn. 3-14 Degree of 
ionization at a 
tissue pH  
 1]101[1  tissuepHpKafi  for monoprotic bases  
12 ]10101[1 21 
 
tissuepHpKapKatissuepHpKafi  for diprotic 
bases  
1]101[1  pKatissuepHfi   for monoprotic acids  
12 ]10101[1 21 
 











Separation of classifier groups 
For researchers requiring Kp prediction for a novel compound, the availability of input 
parameters will not be consistent. For example, when in vivo work has not been done on the 
compound, researchers are likely to have only physico-chemical input parameters and lack any in 
vivo input parameters such as muscle Kp. Therefore, a decision tree incorporating algorithms that 
require in vivo inputs will not be useful for the researcher. Based on this, several versions of the 
classification trees were created and were based on the likely groupings of input parameters 
researchers may have. Any additional algorithm-specific input parameters that were required 
were estimated using the equations in Table 3-2.  
The development and evaluation of Classification tree #1 was dependent on compounds for 
which muscle Kp, one of the lipophilicity measures (e.g. LogP), pKa, and fup were available 
(Table 3-4). The development and evaluation of Classification tree #2 was dependent on 
compounds for which Vss, one of the lipophilicity measures, pKa and fup were available. The 
development and evaluation of Classification tree #3 was dependent on compounds for which 
one of the lipophilicity measures, pKa and fup were available. The algorithms that were 
classified in each of the Classification trees are listed in Table 3-4 along with the number of 









Table 3-4. Physicochemical and/or in vivo parameter inputs for a classifier algorithm and 
included algorithms for each group.   
 Inputs for classification Algorithms 
Group 1 
(N=107 compounds) 
















Jansson et al. 
[5]
 



















Jansson et al. 
[5]
 























Kp calculations according to the previously published algorithms   
To ensure that the use of estimated input parameters as defined in Table 3-3 produced Kp 
predictions that were similar to those predicted using existing algorithms, a comparison of 
outcomes was completed.  Kps were calculated according to each published equation using only 
those input parameters required for Classification trees #1 through #3 and using estimation 
equations for any remaining inputs required.  For Rodgers et al.’s method, Kps of bases with 
pKa   were calculated by Rodger et al. [8]. LogKvo:w and B:P were estimated by Eqn. 3-7, 
Eqn. 3-12 (Table 3-2). Kps of acids, neutrals, and weak bases were calculated by Rodgers et al. 
[9]
. 
In Jansson’s algorithm 
[5]
, Kp prediction equations of bases and neutrals, and Kp prediction 
equations of acid and zwitterions were separately used. For Classification Tree #1, the 
experimentally derived muscle Kp value was used as an input. For Classification Tree #2, 
experimental Vss was used as a direct input for those algorithms requiring it and was used to 
estimate muscle Kp in those algorithms where muscle Kp was an input (Eqn. 3-13). LogD and 
LogKvo:w were calculated as a function of LogP using Eqn. 3-6 and Eqn. 3-7. In Schmitt’s model 
[6]
, compound class was separated by acids, neutrals, bases, and zwitterions and Kps were 
calculated accordingly. LogMA and LogHSA were estimated using the regression equations Eqn. 
3-8 and Eqn. 3-9. In the Yun and Edginton algorithm 
[19]
, Kps were estimated by using equations 
for moderate to strong bases and equations for acids, neutrals and zwitterions. The degree of 
ionization at a specific tissue pH was calculated using Eqn. 3-14. Since Poulin and Theil’s Kp 
prediction approach 
[7]
 was targeted for predicting Kps for bases, only Kps of bases were 
estimated. In Bjorkman’s model 
[4]
, Kp prediction equations for acids and bases were separately 
developed and Kps were calculated accordingly.   
 
 54 
 The difference between calculated Kp values using both experimental and estimated input 












Poulin and Theil 
[7]
 as the calculated Kps were not presented in their publications.   
Mean fold error (MFE,  Eqn. 3-16), average fold error (AFE, Eqn. 3-18), absolute average fold 
error (AAFE, Eqn. 3-19), and root mean square error (RMSE, Eqn. 3-20) were used to measure 
the deviance of the published algorithm predicted Kps and the Kps calculated using experimental 
and estimated inputs (Table 3-5).   
Table 3-5. Statistics for comparative assessment of prediction accuracy 
 Metrics Formula 





Where Predi is predicted value, Obsi is observed value. 





































, I(·) is an indicator 
function, k= 1.25,1.5,2,3
 


































































Using the compound specific properties and the in vivo parameter data in Group 1, 2, and 3 
(Table 3-4), a comparison of experimentally derived Kps with predicted Kps from each applicable 
algorithm were made. The Kp prediction algorithm that resulted in a value that was closest to the 
experimental one was selected for the compound. The selected model for the compound was then 
coded numerically so that the compound could be categorized by the best predicting model 
(coded as in Table 3-6). This coded information was used as the dependent variable in the 
statistical analysis. In order to determine which Kp prediction method should be used for a given 
physicochemical space, statistical methodologies such as ‘recursive partitioning method’, 
random forest, and bagging were investigated in this study. A classification learning algorithm 
that identified the best prediction Kp algorithm with a lower classification error rate was chosen 
for this study.     
 
Recursive partitioning and Classification learning algorithms 
The recursive partitioning, bagging, and random forest methods were utilized to build a classifier 
that identified the most accurate Kp prediction model. Those classification analyses were 
performed using the statistical software R (version 2.14) 
[48]
. Recursive partitioning is 
implemented in the rpart package. After an unpruned classification tree was grown, by using the 
function of printcp(), the cross-validated prediction error for different numbers of splits was 
calculated. A tree was pruned by setting the complexity parameter that resulted in the smallest 
cross-validation error. 
Random Forest is implemented in randomForest package (4.6-6) 
[48,65]
. Initially, the parameters 
were set to the number of trees in a forest (ntree= 500) and number of variable (mtry =   ) by 
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default. By using rfcv function embedded in the randomForest package 
[48,69]
, the optimal mtry 
that resulted in the smallest cross-validated error was chosen. A final random forest model was 
generated by setting the optimized variable of mtry when trees are grown. The Bagging function 
is implemented in the ipred package 
[48,72]
. In this analysis, unpruned classification trees were 





Evaluation of classification performance of random forest, bagging and recursive partitioning 
In order to find the most appropriate classification method, the output of 3 methods: random 
forest, bagging and recursive partitioning were compared. Using the same development dataset 
of n=99 (80% of the total dataset), tissue specific classification trees using recursive partitioning, 
bagging and random forest were generated. The sample R-code is shown in the Appendix 5. The 
rate of correct classification was used as a metric to determine which classification method 
performed best within this study. The rate of correct classification of each method was obtained 
using an independent test set of n = 23 compounds (20% of the total dataset). The classification 
method that resulted in the highest rate of correct classification in the most tissues was chosen 
for this study (Eqn. 3-21).  







Where I(•) is an indicator function, Obsi is observed classification, Predi is predicted 





Evaluation of the random forest using cross validation  
The developed random forests for Classification tree #1, Classification tree #2 and Classification 
tree #3 that corresponded to each group in Table 3-4, were evaluated. The predictive performance 
of each Classification tree was evaluated with the total dataset by using 20 fold cross validation 
[70]
. This method assumes that a random forest developed from 95% (19/20) of a total dataset is 
reasonably the same as a final random forest that is developed using 100% of the total dataset. 
The sample R-code is shown in the Appendix 6.   
 
The steps taken in the 20 fold validation and analysis were as follows:  
(i) The total dataset was partitioned into 20 subsets.   
(ii) A random forest was created using a training set comprised of 19 subsets. The 
developed random forest then predicted the classification for samples in the 20
th
 
subset as a test set. The predicted classification (e.g. best algorithm for compound X 
= Jansson et al.
[5]
) for the test set was recorded. This step was repeated 20 times so 
that each subset was used only once as a test set. As a result, each compound was 
used once as a test compound.  
(iii) For the test dataset that includes all compounds, each compound is associated with a 
random forest generated best prediction algorithm.  
(iv) The rate of correct classification is calculated (Eqn. 3-21).  
(v) The Kp is calculated using the algorithm identified as the most accurate during the 
cross-validation (Table 3-6).   
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Using this method, the predictive performance of previously published algorithms was compared 
to the random forest generated Kps with the use of the same total dataset (n=122 compounds, 




Table 3-6. An example of a dataset for the random forest analysis and corresponding calculated Kp values.   
Compound Observed 
Heart Kp 
1.Berezhkovskiy [12] 2.Rodgers et al. [8,9] 3.Schmitt [6] 4.Jansson et al. [5] 5.Yun and Edginton [19] Code1a Code2 b Predicted Kp  
by a  random forest 
Compound1 3.87 5.74 8.18 27.59 14.84 4.39 5 5 4.39 
Compound2 5.71 1.41 7.24 22.07 5.22 8.99 4 4 5.22 
Compound3 2.61 1.02 0.72 1.64 2.74 3.62 4 2 0.72 
Compound4 1.66 1.28 1.04 3.99 6.67 6.75 1 1 1.28 
Compound5 0.55 0.85 0.64 1.09 1.23 1.97 2 4 1.23 
a Code1 is the coded information of the best predicting model for the compound.  




Model evaluation – Comparative prediction accuracy  
The prediction accuracy of each Classification tree was compared to the prediction accuracy for 
each existing algorithm within its group (Table 3-4). This means that, using inputs required by 
the Classification Tree with all others estimated based on Table 3-3, the prediction accuracy of 
the Classification Tree was compared to the prediction accuracy of each algorithm in the group.   
Prediction accuracy was based on a comparison of the predicted and observed Kps for each 
algorithm. To assess the overall precision of each algorithm, the root mean squared error 
(RMSE) was calculated (Eqn. 3-20) as well as the overall percentage within k-fold deviation 
(k=1.25, 1.5, 2, 3). Tissue specific RMSE was also calculated for comparison of precision of the 
models with respect to the tissue. As a measure of bias, the average fold error (AFE) was 
calculated for each Classification tree (Eqn. 3-18). The AFE indicates an under-prediction (AFE < 
1) or an over-prediction (AFE > 1) compared to the observed values. The absolute average fold 
error (AAFE) quantifies the overall magnitude of the deviation between the predicted and the 
observed Kp values (Eqn 3-1). Second, using the predicted values from previously published 
algorithms (e.g. Jansson et al.
[5]
, Rodgers et al. 
[8,9]
) the same procedure (i.e. % within k-fold 
error, AFE, AAFE, global and tissue specific RMSE calculations) was conducted. The accuracy 
of prediction for each Classification tree was compared to each of the previously published 
algorithms within its group to assess if any one previously published algorithm performed better 






The dataset was comprised of a total of 122 compounds with 852 Kps in 11 tissues (Appendix 7 
and 8). The physicochemical properties and in vivo properties were gathered from the literature. 
The dataset consisted of 29 acids, 70 bases (63 moderate to strong bases with pKa ≥ 7.4 and 7 
weak bases with pKa ≤ 7.4), 12 neutrals, and 11 zwitterions (Figure 3-2).  
 
Figure 3-2. Proportion of molecular species of compounds in the total dataset 
 
Kp calculations according to the previously published algorithms   
Predicted Kps as published by existing algorithms were compared to Kps predicted using 
experimental input data and estimation equations for input parameters not required for 
Classification tree use. The Kp predictions deviated from the original published predictions 
(Table 3-7, Table 3-8, Table 3-9); however, the mean fold error per tissue was comparable to that 




Weak bases, 6% 
Zwitterions, 9% 
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Table 3-7. Comparison of predicted Kps from Rodgers et al. 
[8,9]
 vs. those predicted using experimental/estimated input parameters.  
  Adipose Bone Brain Gut Heart Kidney Liver Lung Muscle Skin Spleen 
Kp predictions 
from Rodgers et al. 
[8]
 
MFE 1.41 4.87 1.62 0.90 1.35 0.93 1.44 0.64 1.57 2.00 1.16 
AFE 1.13 1.27 0.80 0.55 1.17 0.75 0.92 0.44 1.32 1.90 0.83 
AAFE 1.82 2.33 2.62 2.50 1.48 1.76 1.97 2.56 1.62 1.90 2.06 
RMSE 0.33 0.57 0.50 0.53 0.23 0.32 0.36 0.48 0.27 0.32 0.38 
Kp prediction 
using the experimental/estimated 
inputs 
MFE 1.48 7.09 1.48 0.76 1.52 0.96 1.53 0.71 1.62 1.91 0.97 
AFE 1.14 1.17 0.70 0.51 1.22 0.82 0.95 0.43 1.32 1.79 0.78 
AAFE 1.85 2.66 2.89 2.48 1.71 1.63 2.04 2.72 1.62 1.82 1.92 
RMSE 0.34 0.66 0.57 0.48 0.29 0.26 0.40 0.53 0.28 0.30 0.30 
 
 Adipose Bone Brain Gut Heart Kidney Liver Lung Muscle Skin Spleen 
Kp predictions 
from Rodgers & Rowland. 
[9]
 
MFE 1.28 0.67 3.16 1.36 1.06 0.57 0.65 1.40 1.02 2.00 1.23 
AFE 0.97 0.52 2.17 1.04 0.89 0.42 0.45 1.16 0.88 1.69 0.96 
AAFE 1.91 2.05 2.31 1.82 1.68 2.57 2.64 1.67 1.51 1.79 1.72 
RMSE 0.39 0.47 0.47 0.34 0.27 0.53 0.53 0.27 0.24 0.33 0.31 
Kp prediction 
using the experimental/estimated 
MFE 1.10 0.70 3.26 1.37 1.24 0.61 0.68 1.56 0.95 2.08 1.18 
AFE 0.58 0.58 1.87 0.97 0.86 0.39 0.37 1.11 0.77 1.67 0.85 
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inputs AAFE 2.82 1.82 2.29 1.98 1.78 2.89 3.22 1.74 1.63 1.91 1.89 
RMSE 0.66 0.37 0.49 0.39 0.33 0.59 0.63 0.32 0.29 0.37 0.34 
 
Table 3-8. Comparison of predicted Kps from Jansson et al. 
[5]
 vs. those predicted using experimental/estimated input parameters. 
 Metrics Adipose Bone Brain Gut Heart Kidney Liver Lung Muscle Skin 
Kp predictions 
from Jansson et al. 
[5]
 
MFE 1.61 0.77 1.51 1.48 1.20 2.03 4.77 1.90 1.04 1.14 
AFE 0.85 0.74 1.15 1.23 0.95 1.41 1.88 1.47 0.95 1.00 
AAFE 2.16 1.46 1.80 1.66 1.77 2.27 2.46 1.91 1.48 1.47 
RMSE 0.43 0.17 0.33 0.30 0.38 0.44 0.57 0.36 0.20 0.21 
Kp predictions using 
observed Muscle Kp 
 
MFE 2.40 0.78 1.79 1.61 1.13 1.91 3.12 1.46  1.14 
AFE 1.05 0.74 1.15 1.19 0.96 1.34 1.39 1.20  0.99 
AAFE 3.05 1.43 2.30 1.92 1.49 2.14 2.29 1.74  1.51 
RMSE 0.57 0.20 0.48 0.35 0.30 0.41 0.49 0.31  0.24 
Kp predictions using 
estimated Muscle Kp 
 
MFE 2.34 0.77 1.52 1.48 1.13 2.03 4.77 1.76 1.04 1.14 
AFE 1.13 0.74 1.08 1.23 0.93 1.41 1.88 1.36 0.95 1.00 
AAFE 2.67 1.46 1.84 1.66 1.75 2.27 2.46 1.78 1.48 1.47 




Table 3-9. Comparison of predicted Kps from Schmitt 
[6]
 vs. those predicted using experimental/estimated input parameters. 
 
 






MFE 9.06 3.43 12.59 2.70 4.09 1.27 1.91 1.20 1.78 4.89 0.92 
AFE 4.45 1.30 7.18 1.35 2.52 0.68 0.80 0.77 1.23 2.82 0.78 
AAFE 4.63 2.73 7.18 2.65 2.90 2.26 2.42 2.03 1.84 3.02 1.64 





MFE 9.25 5.49 13.25 2.10 3.94 0.99 1.65 1.47 1.49 4.27 1.20 
AFE 4.81 1.01 6.63 1.23 2.73 0.65 0.82 0.75 1.16 2.92 0.93 
AAFE 4.89 2.75 7.36 2.46 3.09 2.01 2.36 2.34 1.83 3.03 2.05 
RMSE 0.84 0.62 0.97 0.48 0.58 0.37 0.48 0.49 0.32 0.57 0.34 
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For Kp calculation according to Rodgers et al. 
[8]
, the prediction accuracy based on the use of the 
previously published estimation equation for B:P (Eqn. 3-11) and the developed regression 
equation (Eqn. 3-12) was compared. The use of the developed regression equation resulted in a 
more accurate prediction in Kps with lower tissue specific RMSE values (Table 3-10). As a 
result, the developed regression equation (Eqn. 3-12) was used in all subsequent calculations.  
 Table 3-10. Comparison of Kp prediction accuracy based on the Rogers et al. 
[8]
 algorithm using either 
the Paixao et al. 
[74]




Adipose Bone Brain Gut Heart Kidney Liver Lung Muscle Skin Spleen 




0.51 0.84 0.78 0.87 0.68 0.75 0.74 1.07 0.58 0.39 0.96 
Regression equation 
(Eqn. 3-11) 
0.34 0.66 0.56 0.48 0.29 0.27 0.41 0.54 0.29 0.31 0.31 
 
With the use of estimated input parameters (e.g. B:P, LogKvo:w), the Kps calculated using the 
algorithm of Rodgers et al. 
[8,9]
 resulted in a under-prediction when compared to Kps calculated 





, with the use of estimated input parameters (Eqn. 3-6, 3-7, 3-8, 3-12), the Kps 
calculated using each algorithm were in agreement with the Kps obtained by both Jansson et al. 
[5]
 and Schmitt 
[6]
 (Table 3-8, Table 3-9, respectively).  
 
Investigation of various classification methods  
Decision trees were developed for 11 tissues as these contained a sufficient number of data 
points for development (Table 3-11). Among several classification methods (i.e. random forest, 
bagging, recursive partitioning), classification performance was explored using the same set of 
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the data. Based on the rate of correct classification, random forest was superior to others with the 
highest correct classification rates in the majority of tissues among each set (Figure 3-3). 
However, the magnitude and standard deviation are similar among the different methods. Thus, 
random forest was deemed to classify the most accurate Kp prediction model based on the 























































































































































Figure 3-3. Rates of correct classification of various classifier algorithms with respect to a 
tissue.  
 
Descriptive statistics of Kp algorithm performance based on the chemical properties  
Using the dataset that consists of 122 compounds, Kps were calculated according to the 
published algorithms.  The best prediction algorithm for each compound-tissue combination was 
assessed. This information was stratified by the compound’s acid-base-neutral properties (Figure 
3-4, left), and LogP values (Figure 3-4, right). For example, for basic compounds, 27% of Kps 
were best predicted by Yun and Edginton 
[19]
. For compounds with a LogP value between -3 and 
1, 27% were more accurately predicted by Jansson et al. 
[5]




Figure 3-4. Schematics of the best prediction algorithms based on molecular species (left), and 
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Construction of predictive random forest models: Classification tree #1, # 2 and # 3   
Three Classification trees were developed using the random forest method. The number of 
samples and the chosen mtry are listed in (Table 3-11). The classification performance of each 
classification tree was indicated by the rate of correct classification. Classification trees resulted 
in a greater rate of correct classification than random permutation rates of 1/6, 1/5, 1/3, based on 
the probability of a correct classification when there are n categories, (1/n). The prediction 
accuracy for each Classification tree was indicated by the percentage of predicted values within 2 
fold of the observed Kps for each tissue. Based on Table 3-11, a high rate of correct classification 
did not always improve Kp prediction accuracy (i.e. percentage within 2 fold of deviation from 
the observed Kps), especially in Classification tree #3. The rate of correct classification for 
Classification tree #1 and #2 was relatively lower than that of Classification tree #3. This was 
because Classification tree #3 had only two or three algorithms to classify whereas Classification 




Table 3-11. Summary of random forest parameter and classification performance.  
 
Classification tree #1 Classification tree #2 Classification tree #3 
n mtry 
Rate of correct 
classification 
% within 2 
fold error 
n mtry 
Rate of correct 
classification 
% within 2 
fold error 
N mtry 
Rate of correct 
classification 
% within 2 
fold error 
Adipose 66 5 0.359 51.6% 65 2 0.384 54.6% 69 4 0.638 60.0% 
Bone 41 5 0.561 73.2% 41 5 0.561 75.6% 42 2 0.643 50.0% 
Brain 78 5 0.385 56.4% 76 5 0.395 51.3% 90 4 0.644 47.8% 
Gut 68 5 0.368 72.1% 65 5 0.446 80.0% 68 4 0.618 60.3% 
Heart 91 5 0.452 83.3% 83 5 0.446 80.7% 96 4 0.563 60.4% 
Kidney 89 5 0.341 73.9% 86 5 0.386 69.8% 94 4 0.684 55.3% 
Liver 84 5 0.243 64.2% 84 5 0.429 63.1% 88 4 0.693 51.1% 
Lung 93 5 0.312 67.8% 85 5 0.365 64.7% 95 2 0.589 56.8% 
Muscle 108 5 0.630 78.7% 93 5 0.355 79.6% 108 4 0.667 80.5% 
Skin 64 5 0.328 77.4% 61 5 0.393 77.1% 64 2 0.719 71.9% 




Comparative assessment of Kp prediction accuracy of Classification trees and published equations  
 -Comparison of prediction accuracy of classification tree # 1 and published equations 
In order to compare the predictive performance of the published algorithms 
[4-9,12]
 and Classification tree 
#1, the tissue AFE, AAFE, and RMSE were calculated using the same dataset (Appendix 7, Appendix 
8). A plot of percentage within k- fold deviation from observed values showed that predictions based on 
Classification tree #1 performed well with 25.6%, 49.7% and 68.8% falling within 1.25, 1.5 and 2 fold 
deviation from the observed Kp values, respectively (Figure 3-5). Global RMSEs of algorithms in Group 
1 indicated that the Kp prediction errors are similar for Jansson et al. 
[5]
, Rodgers et al. 
[8,9]
, and 
Classification tree #1 with values 0.43, 0.51 and 0.49 (Table 3-12). However, Rodgers et al. 
[8,9]
 and 
Classification tree #1 tended to under-predict Kp with AFE values of 0.89, and 0.94, respectively. The 
under-prediction in Kps of Rodgers et al. 
[8,9]
 was observed in bone, kidneys and liver. Jansson et al. 
[5]
 
had the smallest RMSE values of 0.43 but appeared to over-predict Kp with the AFE of 1.27 (Figure 3-6,  
Table 3-12). The over prediction of Kps by Jansson et al. 
[5]
 was observed in kidneys, liver and adipose 
tissue. The overall bias of deviation between the observed Kps and those estimated using Classification 
tree #1 was the smallest among Group 1 with the AFE value of 0.94 (Table 3-12). This is further 
supported by the tissue specific box whisker plot, where the boxes for Classification tree #1 are small, 
centered around zero, and not showing evidence of serious under- or over- prediction. Tissue specific 
RMSEs showed that the Kp prediction of Jansson et al. 
[5]
 resulted in the smallest error for 6 out of 11 




 and Bjorkman’s 
models 
[4]
 tended to over-predict the Kps with an AFE value larger than 1 (Table 3-12). On the other 
hand, Rodgers et al. 
[8,9]
 and Poulin and Theil’s 
[7]
 models tended to under-predict the Kps with an AFE 








































Figure 3-5. Percentages within k fold error. X-acids represents folds, y-axis represent the percentage within k fold error of deviation 
in Group 1.  
 
Table 3-12. Summary of overall predictive performance for Group 1.   
 Berezhkovskiy 
[12]




 Jansson et al. 
[5]
  Bjorkman 
[4]
 Poulin and Theil 
[7]
 Classification tree #1 
AFE 1.14 0.89 1.37 1.27 1.52 0.16 0.94 
AAFE 3.21 2.34 3.36 1.98 2.81 8.34 2.00 




Table 3-13. Summary of tissue specific RMSE of different algorithms in Group 1. 
 Berezhkovskiy 
[12]




 Jansson et al. 
[5]
  Bjorkman 
[4]
 Poulin and Theil 
[7]
 Classification tree #1 
Adipose 0.79 0.47 0.85 0.75 1.20 1.72 0.77 
Bone 0.60 0.55 0.65 0.49 0.64 1.62 0.44 
Brain 0.84 0.58 1.02 0.43 .62 1.39 0.75 
Gut 0.59 0.39 0.50 0.31 0.45 0.72 0.44 
Heart 0.50 0.34 0.63 0.26 0.49 1.08 0.26 
Kidney  0.64 0.54 0.33 0.47 0.93 0.38 
Liver  0.65 0.59 0.51 0.54 1.25 0.54 
Lung 0.76 0.50 0.57 0.34 0.55 1.42 0.37 
Skin 0.45 0.41 0.56 0.23 0.40 1.00 0.32 














































































































































































































































































































































































































































































































































































































































































Figure 3-6. Box and Whisker plot of the logarithm of the ratio between the predicted and observed Kp values of predicted Kps from 
published equations in Group 1 and random forest (Classification tree #1). The boxes represent the median (line) and the 25
th 
and 75th 











 -Comparison of prediction accuracy of classification tree# 2 and published equations 
For comparison of the predictive performance of the published algorithms 
[4-9,12,19]
 and Classification 
tree #2, the tissue AFE, AAFE, and RMSE were calculated. Both Classification tree #2 and Yun and 
Edginton 
[19]
 resulted in more accurate Kp predictions with higher percentages within k- fold deviation 
from observed Kps (k = 1.25 to 3) compared to other algorithms. The prediction performances of both 
Classification tree #2 and Yun and Edginton’s algorithm  
[19]
 were very similar with almost the same 
AFE, AAFE, global RMSE and tissue specific RMSE values (Table 3-14, Table 3-15).  
Favorable Kp predictive performance of both Classification tree #2 and Yun and Edginton 
[19]
 algorithms 
was further reinforced by their AFE values which were closest to 1, and their small AAFE values less 
than 2. The plot of percentage within k- fold deviation from observed values showed that Classification 
tree #2 based Kp prediction performed well with 31.9% and 50.4% falling within 1.25 and 1.5 fold 
deviation from the observed Kp values, respectively (Figure 3-7). 
 In 6 out of 11 tissues, Yun and Edginton algorithm 
[19]
 resulted in the smallest error associated with Kp 
estimates (Table 3-15). Jansson et al. 
[5]
 showed an over-prediction in Kps that was mainly due to the 
over-prediction in the adipose and liver Kps (Figure 3-8). Schmitt’s algorithm 
[6]
 tended to over-predict 
Kps with an AFE of 1.28 and was less accurate with an AAFE of 3.20 (Table 3-14). An over-prediction 
in Kps by Schmitt 
[6]
 was observed in adipose, brain, heart and skin (Figure 3-8). Although 
Berezhkovskiy’s 
[12]
 algorithm resulted in an AFE value close to 1 (1.02), its AAFE value was 2.92. This 
implies that Kp predictions were less accurate and there were both under and over-predictions in the Kps. 
The box whisker plot showed that there was over-prediction in the brain and adipose tissue Kps and an 







































Figure 3-7. Percentage within k-fold error. X-axis represents folds, y-axis represent the percentage within k fold error of deviation in Group 2.  
 
Table 3-14. Summary of overall predictive performance for Group 2.   
Group 2  Berezhkovskiy 
[12]
 Rodgers et al. 
[8,9]
 Schmitt  
[6]
 Jansson et al.  
[5]
 Yun and Edginton 
[19]
 Classification tree #2 
AFE 1.02 0.93 1.28 1.21 1.01 1.03 
AAFE 2.92 2.20 3.20 2.06 1.78 1.82 
RMSE 0.60 0.45 0.64 0.45 0.36 0.37 















 Jansson et al. 
[5]
 Yun and Edginton 
[19]
 Classification tree #2 
Adipose 0.78 0.48 0.85 0.78 0.45 0.50 
Bone 0.60 0.55 0.65 0.51 0.52 0.43 
Brain 0.73 0.57 0.97 0.47 0.50 0.48 
Gut 0.60 0.38 0.49 0.28 0.25 0.25 
Heart 0.46 0.34 0.62 0.42 0.25 0.31 
Kidney 
 
0.49 0.54 0.35 0.37 0.36 
Liver 
 
0.56 0.58 0.50 0.38 0.43 
Lung 0.73 0.47 0.59 0.41 0.32 0.36 
Muscle 0.48 0.29 0.46 0.33 0.28 0.28 
Skin 0.37 0.39 0.54 0.28 0.28 0.26 
Spleen 0.53 0.33 0.52 
 
0.26 0.32 


































































































































































































































































































































































































































































































































































































































































































Figure 3-8. Box and Whisker plot of the logarithm of the ratio between the predicted and observed Kp values of predicted Kps from 













 percentiles.  
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-Comparison of prediction accuracy of classification tree# 3 and published equations 
For comparison of the predictive performance of the published algorithms 
[6,8,9,12]
 and Classification tree 
#3, the tissue AFE, AAFE, and RMSE were calculated. Classification tree #3 resulted in accurate 
predictions in Group 3 with the highest percentages within k-fold deviation from observed Kps (Figure 
3-9), the smallest global RMSE of 0.45, AFE of 0.95 and the smallest AAFE of 2.14. In 9 out of 11 





 algorithms were less accurate with an AAFE larger than 3 and both had a tendency to over-
predict the Kps with an AFE value larger than 1 (Table 3-16). Rodgers et al. 
[8,9]
 under-predicted the Kps 
with an AFE of 0.91. An under-prediction in the Kps by Rodgers et al. was observed in bone, kidneys, 
liver and lungs (Figure 3-10). The global RMSE, AFE, and AAFE values for Classification tree #1, #2 
and Classification tree #3 were comparable. However, in the case of Classification tree #3, the 
percentage within k-fold deviation from observed Kps was lower than Classification tree #1 and #2.  
Group 3
































Figure 3-9. Percentage within k-fold error. X-axis represents folds, y-axis represent the percentage 
within k-fold error of deviation in Group 3. 
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Table 3-16. Summary of overall predictive performance for Group 3.   
Group 3  Berezhkovskiy 
[12]
 Rodgers et al. 
[8,9]
 Schmitt  
[6]
 Classification tree #3 
AFE 1.16  0.91  1.37  0.95  
AAFE 3.18  2.33  3.27  2.14  
RMSE 0.66  0.52  0.65  0.45  
 








 Classification tree #3 
Adipose 0.82 0.47 0.84 0.45 
Bone 0.59 0.54 0.65 0.54 
Brain 0.85 0.61 1.00 0.58 
Gut 0.59 0.39 0.50 0.36 
Heart 0.49 0.36 0.65 0.37 
Kidney 
 
0.64 0.54 0.45 
Liver 
 
0.71 0.57 0.53 
Lung 0.75 0.50 0.57 0.46 
Muscle 0.51 0.37 0.47 0.30 
Skin 0.45 0.41 0.56 0.35 




















































































































































































































































































































































































































































































































Figure 3-10. Box and Whisker plot of the logarithm of the ratio between the predicted and observed Kp 
values of predicted Kps from published equations and random forest (Classification tree #3). The boxes 


















Kp predictions with estimated input parameters 
One of the objectives of this study was to develop a tool to provide Kp prediction when only a limited 
number of parameters are available. Many algorithms require input parameters that are not readily 
available to researchers such as muscle Kp or B:P. As a result, Classification trees were built using 
experimental input parameters that are readily available while estimating those that are not considered 
routinely derived. To assess the use of estimation methods for generally unavailable input parameters, a 
comparison of predicted Kps from published algorithms were compared to the predicted Kps using 
readily available experimental parameters and the estimated input parameters.  
In the calculation of Rodgers et al. 
[8,9]
, it was observed that the use of experimentally determined inputs 
such as B:P and LogKvo:w resulted in more accurate Kp predictions with lower tissue specific RMSEs 
when compared to Kps calculated using estimated inputs (Table 3-7, Table 3-8, Table 3-9). In Rodgers et 
al. 
[8]
, the blood cell to plasma water concentration ratio (KpuBC) is one of the parameters that is not 
directly measured but is estimated using a standard equation (Eqn. 3-10). This equation is a function of 
an experimentally determined B:P 
[73]
. Therefore, the prediction of Kps according to Rodger et al. 
[8]
 is 
sensitive to the accuracy of the B:P measurement. Instead of using an experimentally determined B:P, 
Small et al. 
[76]
 introduced an alternative method that directly measures KpuBC using surface plasmon 
resonance (SPR).  It was discovered that the use of the SPR approach resulted in a more accurate 
prediction of Kpu and therefore Vss 
[76]
. This demonstrates that the more accurate the input, the more 
accurate the predictions. Availability of either experimentally determined B:P or KpuBC is likely to lead 
to a more accurate Kp prediction using the algorithm of Rodgers et al. 
[8,9]
. In reality however, these 
parameters are not often available. In order to overcome this problem, a B:P estimation equation (Eqn. 
3-12) was generated in this study. This equation was used and replaced the previously published 
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estimation approach (Eqn 3-11 
[74]
) as the regression equation produced more accurate Kpus (Table 3-10).  
The use of this regression equation may bring uncertainty to our model. However, the use of this 
equation in Kp calculations using the Rodgers et al. 
[8,9]
 algorithm resulted in Kpus that were comparable, 
although not superior to, Kpus calculated using experimentally determined B:P. The accuracy metrics 
such as tissue specific RMSEs and AFEs were comparable (Table 3-7).  
In the calculation of Jansson et al.’s algorithm 
[5]
, the use of an experimentally determined muscle Kp 
resulted in more accurate predictions in heart, kidney, liver and lung when compared to the prediction 
accuracy of Jansson et al. 
[5]
 that used a muscle Kp that was estimated from Vss (Table 3-8). As a result, 
Jansson et al.’s algorithm 
[5]
 was selected as the best predicting algorithm in Classification tree #1, 
which used muscle Kp as an input, more often than in Classification tree #2, which used Vss as an input. 
Overall, based on similar bias and precision estimates, Kp predictions with the estimated input 
parameters were deemed sufficiently agreeable to Kp predictions from Rodgers et al. 
[8,9]
, Jansson et al. 
[5]




Construction of tissue specific Classification trees #1, #2, and #3  
Because compound distribution is the interplay between compound specific properties (pKa, LogP, and 
fup) and physiologic factors such as tissue composition information (e.g. concentration of acidic 
phospholipids), Kp prediction equations should be able to describe the compound distribution process 
affected by both the physicochemical properties of a compound and the tissue specific physiologic 
factors. Those factors should be well formulated to yield a sufficient prediction. Failure to take into 
account one of the above aspects could result in Kp predictions deviating from the true value.  
The predictive performance of a Kp algorithm may be tissue-dependent. One algorithm may have more 
predictive power for a particular tissue than an alternative algorithm. Furthermore, accurate Kp 
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prediction in some tissues is more difficult than others. For example, Kp predictions in lung, adipose, 
and liver are difficult due to the enhanced probability of ion trapping, the large distribution of lipophilic 
compounds into adipose tissue with a relatively large inter-laboratory measurement error on LogP 
(explained in the discussion of Chapter 2) and the role of extraction in Kp estimates. In order to address 
inter-tissue variability, a Classification tree was created for 11 tissues. For each tissue, Classification 
trees #1, #2 and #3 were constructed that were dependent upon user supplied input parameters (i.e. 
LogP, pKa, fup, Vss, and muscle Kp) as well as estimated input parameters that were required but not 
deemed readily available.  
 
Comparison between classification methods  
In the generation of Classification trees, the classification performances of the three different 
classification algorithms (i.e. recursive partitioning, bagging, and random forest methods) were 
investigated. The algorithm with the highest correct classification ratio was selected for this study. The 
three classification methods differ in their methodologies. One of the disadvantages of using a single 
classification tree derived from the recursive partitioning method is that it can be sensitive to the 
modifications in the training set when compared to a collection of classification trees 
[61]
. The single 
classification tree is unstable due to the numerous potential variables that can lead to a reduction in 
impurity when a split is chosen. In other words, depending on the dataset different splitting criteria can 
be chosen for a node resulting in a different classification. In order to overcome the instability of the 
single classification tree, ensemble methods (i.e. random forest and bagging) are used.  
In the bagging and random forest method, because of the random variation of each bootstrap sample 
drawn from the training data, various classification trees with different splitting criteria were generated.  
By combining the classifications from the trees, there is an increase in the correct classification ratio 
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when bagging or random forest is used. However, the easy interpretability of the single classification 
tree (e.g. Figure 3-1) is not available as an output of the ensemble methods. 
Both random forest and bagging are similar in the use of the same recursive partitioning principle when 
growing a collection of trees. Random forest and bagging methods are different in that, with random 
forest the splitting criteria is chosen from the mtry variable. In the bagging model, the splitting criteria is 
chosen from all of the M number of variables 
[69]
. Random forest grew 500 trees whereas, bagging grew 
25 trees by default in this analysis. Therefore, by optimizing mtry in the random forest, more various 
trees can be grown from the bootstrap subsets than with the bagging method.  
It was observed that, in most tissues, Classification trees #1, #2, and #3 were optimized with mtry values 
close to the maximum number of input variables (e.g. for group 3, M=4: LogP, DOI, fup, and class) 
(Table 3-4). In most cases, the number of variables at each node were the same with mtry=M in both the 
random forest and bagging methods. Whereas for bagging, mtry was always set to be M (i.e. mtry=M). 
Random forest grew trees with a different mtry and among the possible mtry, the optimal mtry was found 
by selecting mtry that resulted in the smallest cross validation error. The large number of trees and 
optimized mtry of random forest led to a more precise classification in this study. Among the 
classification methods, random forest was selected for this study due to the higher rate of correct 
classifications in most tissues (Figure 3-3). 
 
Inherent factors in Kp prediction via a Classification tree 
Kp prediction via a Classification tree depends on two important factors. The first factor is the accuracy 
of each Kp prediction algorithm in each group (e.g. Rodgers et al. 
[8,9]
, Jansson et al. 
[5]
), and the second 
factor is the classification performance of a classifier (i.e. a random forest). Although poor prediction of 
the Kps and/or poor classification by a classifier can lead to an undesirable outcome, there is no clear 
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relationship between the accuracy of a Kp prediction method and the classification performance. The 
rate of correct classification did not always result in the lowest RMSE even though the best performing 
algorithm (e.g. Yun and Edginton 
[19]
) for a certain compound was correctly predicted. This is because 
the predicted Kp from an algorithm that was classified by the random forest can largely deviate from the 
corresponding observed Kp (Table 3-11). Thus, the interplay of these two factors should be taken into 
consideration in the interpretation of the Kp prediction via the Classification trees #1, #2 and #3.  
For example, in the case of heart Kp prediction in group 3, it was observed that Berezhkovskiy 
[12]
 under-
predicted and Schmitt 
[6]
 over-predicted the Kps (Figure 3-10). Classification tree #3 for heart resulted in 
a good predictive performance with the standard deviation of log(pred/obs) being close to zero (Figure 
3-10). As well, Classification tree #3 had a lower tissue specific RMSE of 0.36 compared to the other 
three algorithms (Table 3-17). This indicated that the classifier both performed well in classification 
with a rate of correct classification of 0.56 and improved the Kp prediction accuracy with RMSE of 0.45 
(Table 3-16). This case is an example that supports the hypothesis that the use of a Classification tree 
improves Kp prediction accuracy.  
 
Comparison of Classification tree #1, #2 and #3 
When experimentally determined muscle Kp along with physicochemical parameters (e.g. LogP, pKa, 
and fup) are available, 6 Kp prediction algorithms can be used and these were the algorithms used in 
Classification tree #1. It was observed that the use of Classification tree #1 improved the Kp prediction 
accuracy over any one of the 6 prediction algorithms and resulted in a lower global RMSE and a higher 
percentage within K-fold deviation from the observed Kps (Table 3-12, Figure 3-5).  
Both the Yun and Edginton algorithm  
[19]
 and Classification tree #2 had a high Kp prediction accuracy 




 and Yun and Edginton  
[19]
 models that used Vss had high accuracy and precision in Kp prediction. 
This further implies that the availability of the in vivo parameter Vss and the use of these correlation 
models improve Kp prediction accuracy over TCB algorithms. For the most part, the high prediction 
accuracy with low global RMSE may be due to their good predictive performance in bases. It was 
observed that about 27% and 16% of Kps of basic compounds were best predicted by Yun and Edginton 
[19]
, and Jansson et al. 
[5]




 only require a minimal number of input parameters such as ex vivo fup and 
physicochemical parameters. Classification tree #3 identified the best predicting model based on the 
basic parameters (pKa, fup, LogP) and improved the Kp prediction accuracy over any one TCB 
prediction algorithm alone. It is expected that Classification tree #3 will be the most applicable in early 
drug discovery when compared to Classification tree #1 and #2. This is because the use of the 
Classification tree #1 and #2 is limited by the availability of an in vivo parameter (i.e. muscle Kp or Vss).  
As discussed in the section 2.5 Discussion, correlation-based models are dependent on the dataset that is 
used in their derivation. The correlation model may perform better if the chemical properties of the new 
compound are similar to the chemical properties that were used for the development of the regression 
equations. This is only true if the chemical properties are only the determinants for tissue distribution of 
the compound. In the case where the chemical properties of the new drug are not similar to the chemical 
properties that were used for the development of the regression equations, a TCB model may perform 
better than a correlation model. This is because a TCB model is not empirical but mechanistic. 
Therefore, the performance of Kp prediction algorithms should be evaluated using an external dataset 
that was not used for the development of the correlation model because the prediction performance of a 
regression-based algorithm could be artificial depending on the dataset. Recently, researchers compared 
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the predictive performance of Kp algorithms using Vss as an outcome. Using an independent dataset 
[34]
 
it was found that a correlation model (i.e. Jansson et al. 
[5]
) had better Kp prediction performance than a 
TCB model (i.e. Rodgers et al. 
[8,9]
). However, the TCB models do have an advantage in that they are 
applicable for any species if the tissue-specific physiological parameters are available. For regression 
based algorithms that were built using rat in vivo or ex vivo data, the ratio of rat to the species of interest 
fup have been used for inter-species scaling 
[7]
.  
For the most part, Classification trees had better prediction performance in most tissues (Figure 3-6, 
Figure 3-8, Figure 3-10) with little bias towards over- or under-prediction (Figure 3-6). According to the 
plots of the percentage of predicted Kps within 1.25 and 1.5 fold deviations from the observed Kps, 
Classification trees #1, #2 and #3 had higher percentages when compared to other algorithms in each 
group. Based on these results, it can be concluded that Classifications trees offer advantages over using 
any single algorithm to predict all tissue-specific Kps for a compound.  
 
Limitations of current Kp prediction algorithms  
The accuracy of the TCB method depends on how well the factors describing the underlying process in 
tissue distribution (e.g. compound binding affinity to cell constituents) are formulated. Unreasonable 
formulation in the structure or uncertainty in physiological and/or chemical parameter values can lead to 
poor prediction in Kp. An underlying mechanism of a Kp prediction algorithm may not be true for a 
compound in certain physicochemical space. For example, a different approach was needed to overcome 
the poor Kp prediction accuracy for highly lipophilic compounds. It is known that the high lipophilicity 
of a compound is associated with a large tissue distribution (i.e. large Kp, large Vss). Rodgers et al. 
[77]
 
demonstrated that Vss increases exponentially when LogP increases above a LogP of 6. In terms of the 
currently available algorithms (e.g. Jansson et al., Rodgers et al., Yun and Edginton), all equations are 
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designed such that an increase in lipophilicity leads to the increase in Kp values. Above a certain LogP 
value, however, this relationship between distributional parameters and LogP may not hold true as Kp 
and/or Vss may reach a plateau 
[15,78]
.  Therefore, in Poulin and Haddad’s simplified model 
[79]
 for highly 
lipophilic compounds (logP > 6), regardless of a compound’s acid-base-neutral properties, compound 
partitioning into neutral lipids is prevalent 
[79]
 and the plateau concept holds true. In the present study, 
the range of LogP values was -3 to 6. This means that all of the algorithms included in the Classification 
trees are not appropriate to use with compounds where LogP is greater than 6. Therefore, user caution is 
recommended for Kp prediction of highly lipophilic compounds (LogP > 6). As drug compounds tend to 
have LogP values less than 6, this is not expected to affect the accuracy of small drug molecule Kp 
prediction. For environmental contaminants however, LogP values often exceed 6 and the use of certain 
algorithms will over-predict Kps.  
In the presence of transport carriers, there would be a discrepancy between true Kp and the estimated Kp 
under the assumption of no carrier mediated tissue partitioning. The empirical model for estimating Kps 
is highly dependent on the development dataset. If a dataset is comprised of numerous compounds for 
which tissue distribution is affected by active transport, those observations in the dataset can be 
influential in determining the coefficient of an equation which can lead to the poor Kp prediction of a 
new observation. The relationship between in vivo parameters, chemical properties of a compound and 
tissue Kps is not currently robust enough to describe the tissue partitioning in the presence of carrier-
mediated distribution. Thus, user discretion is recommended in the use of Kp prediction algorithms for 
compounds that are significantly affected by elimination and active transport. Despite this limitation, the 
predictive performance of the proposed algorithm was evaluated. It was found that the proposed 
algorithm had higher tissue-specific prediction accuracy than previously published Kp prediction 
algorithms in most tissues. 
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One of the advantages of Kp prediction algorithms is to provide an estimation of Kps based on 
physiological and physicochemical parameters without experimental determination in animals. A Kp 
prediction algorithm is a simplified model (i.e. assumption of passive diffusion of compounds) and may 
overlook important biological processes (such as elimination or carrier mediated distribution). However, 
in the process of building a PBPK model, this passive diffusion Kp is the desired input parameter. The 
effect of extensive metabolism in an eliminating organ or the effect of transporters in tissue distribution 
is taken into account, not through a Kp, but through the incorporation of the enzyme or transporters.   
3.6 Conclusion 
The Classification tree based Kp prediction requires readily available parameters such as LogP, pKa, 
fup, and in vivo parameters (i.e. a muscle Kp or Vss). Classification trees have the advantage of using the 
best predicting algorithm for a compound within a specific tissue. Each algorithm has its unique theory 
in the Kp prediction and different underlying processes are previously described (Chapter 1 
Introduction). For example, some algorithms put more emphasis on the fact that electrostatic binding of 
basic compounds to phosphophatidylserine mainly drives tissue partitioning. Other algorithms focus on 
the relationship between muscle Kp and lean tissue Kps, and predictive regression equations were 
derived using this relationship. Based on readily available compound-specific parameters, the 
Classification tree classified and identified which algorithm best described the tissue partitioning for a 
compound. As a result, the Classification tree based Kp prediction improved accuracy over using any 




Conclusions and future work 
Tissue-to-plasma partition coefficients (Kp) that characterize the tissue distribution of a compound are 
important input parameters in PBPK models. This study proposed two different approaches for Kp 
prediction. Predictive regression equations that use readily available parameters were developed. This 
approach is computationally simple, but the use is limited to the availability of the in vivo parameter of 
Vss. It was found that the developed regression equations had greater prediction accuracy in comparison 
to published Kp prediction algorithms. 
In terms of the Classification tree based Kp prediction method, the use of previously published 
algorithms and the identification of the most accurate algorithms resulted in a competitive Kp prediction 
over any one algorithm alone. This was particularly evident with Classification tree #3 that identified the 
best tissue composition model and greatly improved a priori Kp prediction. In the absence of in vivo data 
(i.e. muscle Kp and Vss), Classification tree #3 had better predictive performance when compared to 
using a single TCB model.  
One of the limitations of the Classification tree based Kp prediction is that it is mathematically 
complicated. In order to overcome this problem, the Classification trees will be available as a web based 
program for public consumption as a future work. This will feature the Classification tree calculator that 
will define the best predicting algorithm as well as a Kp calculator for calculating Kp from the best 
predicting algorithm. This program will be used as a tool for Kp prediction and requires only a minimal 
number of input parameters (i.e. LogP, pKa, fup, Vss and/or muscle Kp).  
 
In conclusion, this study proposed an improved Kp correlation algorithm and a novel Classification tree 
that led to a more accurate Kp prediction. Classification tree based Kp prediction overcomes the 
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limitations of any one algorithm by harnessing the best components of each algorithm. The predictive 
performances of the two methods were demonstrated to be superior to previously published Kp 
algorithms. An accurate prediction of target site concentrations is of great importance as this 
concentration drives pharmacological response. Increased prediction accuracy of Kps will lead to the 






Appendix 1. Development set A of moderate to strong bases to construct a predictive regression equation. 
Drug LogP pKa Drug Classa fup Vss 
(L/Kg) 
Adipose Bone Brain Gut Heart Kidney Liver Lung Muscle Skin Spleen 
Acebutolol-R [80] 1.79 9.7 B 0.79 9.33 1.10 0.06 0.48 22.43 5.71 23.58 31.48 10.31 4.97 3.01  
Acebutolol-S [80] 1.79 9.7 B 0.73 8.90 0.79 0.04 0.36 91.25 4.30 32.70 24.89 6.14 4.45 2.47  
Betaxolol-R [80] 2.59 9.4 B 0.53 20.99 2.95 13.20 12.93 40.23 23.59 58.30 130.91 203.52 13.78 6.52  
Betaxolol-S [80] 2.59 9.4 B 0.54 19.75 2.86 12.85 13.01 37.80 21.52 54.54 108.00 182.52 13.55 6.05  
Bisoprolol-R [80] 1.87 9.4 B 0.85 6.92 1.03 4.88 1.64 26.52 6.49 24.91 22.78 41.82 5.40 2.18  
Bisoprolol-S [80] 1.87 9.4 B 0.85 6.72 1.02 4.43 1.79 25.67 6.69 24.82 22.95 41.99 5.23 2.21  
Caffeine [81] 0.17 10.4 B 0.97 0.71 0.23 0.89 0.60  0.56 0.93      
Carvedilol-R [80] 4.19 8.1 B 0.02 1.79 0.80    1.94 1.92 4.52 34.00 0.81   
Chlorpromazine [2] 5.42 9.7 B 0.11 29   11.50         
Cocaine [2] 2.30 8.6 B 0.63 2.80 5.16  7.02 6.94  13.18   3.02   
Cotinine [2,29] -0.25 8.1 B 0.97 0.43 0.08  0.42 0.64 0.51 0.99 0.64 0.63 0.67   
Haloperidol [2] 4.30 8.7 B 0.23 10  27.20 13.37 10.80 14.30   53.50 29.00 6.20  
Inaperisone [82] 3.50 9.0 B 0.24 6.35 16.00  12.00  7.40 58.00 34.00 33.00 4.10 6.30  
Lidocaine [2] 2.44 8.0 B 0.38 2.62   3.24 3.12 2.73 17.21 11.51 3.80 1.68 2.58 4.79 
Metoprolol-R [80] 2.01 9.7 B 0.80 7.87 1.04 5.18 6.48 12.96 6.89 26.56 40.04 25.56 5.66 3.19  
Metoprolol-S [80] 2.01 9.7 B 0.81 7.74 0.98 5.33 6.97 11.22 6.25 26.89 44.59 26.57 5.57 2.92  
Morphine [83] 0.82 8.3 B 0.72 5.18      9.50 1.20  2.50   
Nicotine [84] 1.17 7.8 B 0.84 1.53 0.32  2.02 1.60 1.12 18.14 4.95 1.24 1.23 1.10  
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Oxprenolol-R [80] 2.18 9.5 B 0.24 2.80 0.58 1.87 1.29 12.71 3.62 14.17 8.59 15.86 3.08 1.37  
Oxprenolol-S [80] 2.18 9.5 B 0.36 3.74 0.69 2.33 2.48 11.18 4.37 17.62 12.33 21.24 3.89 1.70  
Pentazocine [2] 3.31 8.5 B 0.46 7.66 2.50 5.40 4.30 4.70 5.40 20.00 2.30 27.00 5.90 4.70  
Pethidine [80] 2.45 8.6 B 0.15 13.20 4.17   16.60   262.28 24.24 5.20   
Pindolol-R [80] 1.75 9.0 B 0.51 4.32 0.88 2.71 5.10 26.01 13.87 47.40 14.36 33.58 8.08 2.86  
Pindolol-S [80] 1.75 9.0 B 0.76 8.59 0.62 2.29 5.17 18.32 9.27 29.79 7.24 30.32 7.28 2.74  
Procainamide [2] 0.88 9.2 B 0.92 1.77 0.13  2.47  2.48 6.38 3.19  4.38   
Propranolol [2] 3.22 9.4 B 0.08 13.04   14.00 6.60 7.10 15.30 11.60 16.46 4.30  14.20 
Propranolol-R [80] 3.48 9.5 B 0.02 1.88 0.65 1.39 6.51 6.27 3.86 6.19 5.56 24.24 1.89 1.09  
Propranolol-S [80] 3.48 9.5 B 0.13 10.13 2.41 6.73 35.69 23.11 15.75 35.31 29.34 131.70 9.40 5.21  
Pyridostigmine [2] -3.73 10 B 0.50 0.35     1.10 15.20 2.10  0.52   
Theophyllin [2] 0.26 8.7 B 0.60 0.95   0.36     0.71 0.60   
Verapamil [2,85] 3.79 8.5 B 0.05 4.40     6.00 12.50  50.00 3.50   
Quinidine [86] 3.40 9.3 B 0.33 8.94   1.16 14.42 8.92 19.51 20.79 44.03 3.82  23.99 
Timolol-S [80] 1.87 9.2,8,8 BZ 0.63 5.20 0.64 1.00 1.06 20.16 5.36 13.32 7.87 26.96 4.15 1.58  
Enoxacin [87] 0.10 8.7,6.1 BZ 0.66 1.57  1.44   1.07 4.61 3.21 1.14 1.45 1.36 1.63 
Ofloxacin [87] -0.40 8.2,6.1 BZ 0.77 1.50 0.19 1.42 0.24  1.78 6.39 2.04 1.36 1.72 1.19 1.93 
Tetracycline [88] 0.03 9.7,7.7,3.3 BZ 0.50 2.20 1.10 8.11  3.75  4.05 4.70  1.62   
Pefloxacin [87] 0.42 7.6,6.3 BZ 0.77 2.75   0.16  2.36 4.13 5.34 1.94 2.41  3.42 
JNJ1/Domperidone [89] 3.96 7.9 B 0.09 7.40 3.21  0.12  3.87 22.50 13.80 10.90 3.45 4.35  
JNJ13/Prucalopride [89] 2.26 8.5 B 0.71 4.90   0.43  4.30 17.60 8.77 10.60 4.57   
JNJ14/Sabeluzole [89] 4.63 7.8 B 0.02 5.85 8.41 1.83 5.37  2.45 10.40 37.70 29.20 0.83 2.95 5.48 
JNJ15/Lubeluzole [89] 4.88 7.6 B 0.01 4.24   4.13   9.90 27.70 18.10 2.04   
JNJ18/Laniquidar [89] 5.50 7.9 B 0.00 8.95   2.86  5.82 12.00 16.80 38.70 7.07   
JNJ2/Nebivolol [89] 4.03 8.4 B 0.02 5.20   3.73  4.71 10.60 14.10 99.70 2.95   
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JNJ28/Sufentanil [89] 4.02 8.1 B 0.07 4.32 7.72  2.08  1.80 1.17 0.37 6.18 1.71  2.80 
JNJ29 [89] 4.18 8.9 B 0.06 12.90   11.60  13.70 25.30 63.80 122.00 8.00   
JNJ3/Galantamine [89] 1.09 8.2 B 0.76 5.18   1.51   13.90 2.53  2.14   
JNJ30 [89] 4.90 7.7 B 0.02 7.11   1.26  2.61 18.10 12.00 47.70 7.73   
JNJ33 [89] 2.08 8.3 B 0.63 3.00   0.24  3.00 13.80 8.90 7.80 2.60   
JNJ37 [89] 4.60 9.1 B 0.04 32.70   34.00  36.00 44.00 212.00 297.00 14.00   
JNJ6/Loperamide [89] 5.13 8.9 B 0.02 4.42      9.30 5.00 35.90    
JNJ7 [89] 2.47 7.8 B 0.53 3.28     4.44 18.10 31.00 11.70 4.40   
JNJ8 [89] 1.18 9.9 B 0.82 7.08     5.15 29.70 45.90 12.20    
JNJ9/Cisapride [89] 4.22 7.9 B 0.08 4.73   1.56  1.93 7.32 17.10 10.80    
Ketanserin [90] 3.30 7.5 B 0.01 0.67 0.56 0.19 0.19  0.35 1.53 2.60 1.49 0.28 0.46 0.91 
Risperidone [90] 3.04 8.2 B 0.12 1.77   0.23  0.82 0.64 12.30 3.42    
Levocabastine [90] 1.75 9.3,3.2 BZ  0.47 1.36 0.84 0.52 0.59  1.19 8.52 14.00 1.49 0.88 0.98 1.32 
Norfloxacin [2] -1.03 8.8,6.6 BZ 0.58 2.05        1.34 0.92   
Grepafloxacin [91] 1.17 9.08,6.08 BZ 0.59 5.42    6.06 5.19 15.01 11.46 20.23 3.54   
Sparfloxacin [92] 0.21 9.08,5.84 BZ 0.55 3.42 0.18  0.00 9.87 2.09 7.55 4.50 2.45 1.93 2.08  
a




Appendix 2. Development set B of acids, neutrals and weak bases to construct a predictive regression equation.  
Drug LogP pKa Drug Classa fup Vss 
(L/Kg) 
Adipose Bone Brain Gut Heart Kidney Liver Lung Muscle Skin Spleen 
Penicillin [93] 1.64 2.8 A 0.15 0.24    0.97 0.10 3.71 0.25 0.16 0.06  0.10 
Salicylic acid [94] 2.26 4.0 A 0.40 0.19  0.14 0.06 0.66 0.19 0.44 0.23 0.19 0.13 0.27  
Valproic acid [9] 2.75 4.6 A 0.37 0.66 0.15  0.07 0.45 0.43 1.50 1.80 0.42 0.16 0.47  
Glycyrrhizin [2] 2.80 5.3 A 0.05 0.06     0.25   0.06 0.06 0.15 0.07 
Tenoxicam [92] 1.86 5.3 A 0.02 0.13 0.02 0.08 0.01 0.17 0.14 0.78 0.86 0.24 0.06 0.12 0.07 
Fleroxacin [2] 0.24 6.5 A 0.75 1.30  1.20   2.55   2.00 2.00 1.20  
5-hexyl-5-ethyl barbituric acids [95] 2.79 7.7 A 0.19 0.94 6.14  1.66 1.61 1.56 2.28 3.34 1.07 1.20 2.13 0.84 
5-n-Ethyl-5-ethyl barbituric acids [95] 0.68 7.8 A 0.95 0.51 0.42 0.63 0.68 0.59 0.73 1.71 1.64 0.84 0.70 0.77 0.52 
5-propyl-5-ethyl barbituric acid [95] 0.77 7.8 A 0.87 0.56 0.77 1.30 0.91 0.81 1.03 2.81 1.68 1.12 0.90 1.00 0.53 
5-octyl-ethyl-barbituric acid [95] 3.82 7.8 A 0.00 0.44 5.13  1.87 1.32 1.47 2.52 3.47 3.06 0.80 1.91 1.87 
5-n-heptyl-5-ethyl barbituric acids [95] 3.64 7.8 A 0.07 0.56 5.55  1.13 1.34 1.33 2.05 2.23 1.20 0.90 1.46 1.25 
5-n-butyl-5-ethyl barbituric acids [95] 1.70 7.8 A 0.61 0.57 1.31 0.98 1.17 1.23 1.45 3.24 2.09 1.05 0.90 1.09 0.36 
5-nonyl-5-ethyl barbituric acid [95] 4.07 7.8 A 0.01 1.34 5.83  2.49 2.04 2.07 4.07 3.76 2.65 1.00 2.76 3.09 
5-pentyl-5-ethyl barbituric acid [95] 2.20 8.0 A 0.50 0.74 1.63 0.49 0.91 0.82 0.91 2.27 1.72 0.65 0.70 1.11 0.33 
Hexobarbital [29,96] 1.74 8.1 A 0.70 1.20 1.60   1.43 1.28 1.50 6.00 2.81 1.00 0.95  
5-n-Methyl-5-ethyl barbituric acids [95] 0.05 8.1 A 1.00 0.71 0.27 0.98 0.63 0.59 0.68 1.30 1.50 0.73 0.60 0.76 0.70 
Phenytoin [4,97] 2.47 8.2 A 0.12 1.39 1.64  0.70 1.24 0.71 1.60 2.30 0.72 0.70 0.94  
Nalidixic acid [87] 1.10 5.1,3.3 Z 0.29 0.38  0.29 0.22 0.49 0.49 0.54 0.58 0.33 0.36 0.35 0.00 
Ftorafur [9] -0.27  N 0.78 0.34 0.17  0.41 0.36 0.38 0.68 0.39 0.26 0.50 0.40 0.42 
2,3-Dideoxyinosine [2] -1.24  N 0.98 0.51   0.46 0.51  6.86 0.77  0.69  0.96 




A: acid, N: neutral, WB: weak base, Z: zwitterion 
 
Appendix 3. Test set A for moderate to strong bases to evaluate prediction accuracy.   
Drug LogP pKa Drug Classa fup 
Vss 
(L/Kg) 
Adipose Bone Brain Gut Heart Kidney Liver Lung Muscle Skin Spleen 
Biperiden [2] 4.25 8.8 B 0.17 14.00 67.64 2.28 7.95 12.92 8.04 12.13 
 
86.31 3.69 4.70 
 
Carvedilol-S [80] 4.19 8.1 B 0.04 3.36 1.90 
   
7.42 7.00 11.77 75.60 1.60 
  
Digoxin [2] 1.23  N 0.73 0.99    5.91 1.65 2.07 15.19 2.09 1.40   
Prednisolone [2] 2.02  N 0.23 1.37   0.48  0.67   0.66 0.35   
Clobazam [2] 1.84  N 0.25 3.29         2.60   
Cyclosporin [98] 2.90  N 0.08 3.62 11.57 3.18 0.79 5.23 4.05 7.99 12.20 5.52 1.35 2.92 5.45 
Propofol [2] 3.79  N 0.03 9.90   8.20  4.33  13.07 4.41 1.06   
Triazolam [3] 2.40  N 0.28 2.24 6.02 0.00  11.90  8.43 3.75  6.02 5.46  
Alprazolam [3] 2.21  N 0.35 1.98 1.08 0.95 1.88 1.67 1.69 3.68 8.39 3.15 2.00 2.96  
Chlordiazepoxide [3] 2.40  N 0.15 1.45 4.31 0.00 0.75 1.97 2.61 2.70 4.85  0.77 0.48  
Midazolam [3] 3.01 5.9 WB 0.04 2.38 4.62 1.92 2.49 2.81 4.64 3.19 8.51 4.08 0.87 1.96 2.42 
JNJ17 [89] 7.00 6.8 WB 0.02 6.94   0.79  4.84  11.70 20.60 2.95   
JNJ20 [89] 3.23 7.0 WB 0.08 1.58   1.34  1.45 4.47 7.44  0.67   
JNJ23 [90] 3.40 7,3.1 WB 0.08 1.58 2.53 0.69 1.39  1.34 4.03 8.64 2.48 0.67 0.92 3.35 
JNJ25 [89] 4.43 7.2 WB 0.04 6.47   0.63  3.39 8.25 21.40 22.90 1.47   
JNJ21 [90] 4.17 7.2 WB 0.01 7.35   1.15  1.53 2.95 15.90 3.49 0.49   
JNJ24 [89] 4.69 7.3 WB 0.02 10.70   4.55  7.41  20.90  4.50   
Ridogrel [90] 3.54 4.9,3.8 Z 0.05 0.78   0.18  0.39 0.25 1.39 0.37 0.11   
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Fentanyl [53,99] 3.97 8.7 B 0.16 4.58 26.70 
 
3.53 8.36 4.50 12.09 3.80 13.50 3.09 2.09 27.60 




2.90 5.67 0.57 19.40 2.82 
  
Imipramine [53] 4.62 9.5 B 0.24 18.69 7.35 
 
22.99 26.66 21.91 54.19 121.28 141.22 9.91 1.68 57.36 




2.19 11.80 8.04 40.98 1.51 
  
Lomefloxacin [87] -0.30 9.3 B 0.72 1.30 0.27 1.58 0.22 1.63 1.37 4.84 2.30 1.24 1.61 0.94 1.73 
Pipemidic acid [87] -2.15 7.5,4.9 Z 0.82 2.31 0.34 2.02 0.13 
 
0.89 7.41 4.61 1.03 1.05 
 
1.35 





   
2.30 
  









B: base, Z: zwitterion  
Appendix 4. Test set B for acids, neutrals and weak bases to evaluate prediction accuracy.   
Drug LogP pKa Drug Classa Fup Vss 
(L/Kg) 
Adipose Bone Brain Gut Heart Kidney Liver Lung Muscle Skin Spleen 
Thiopental [4] 2.85 7.5 A 0.18 0.19 8.00  0.70 1.32 1.40 3.09 2.29 1.54 0.88 1.18 0.53 
Tolbutamide [101] 2.34 5.5 A 0.24 0.20 0.13  0.10 0.12 0.27 0.22 0.30 0.25 0.13 0.22 0.19 
Cefazolin [93] 0.28 2.3 A 0.15 0.40  0.11  0.17 0.10 2.77 0.77 0.19 0.09 0.30  
Ceftazidime [102] -0.50 3.92,2.5,1.9 Z 0.10 0.24 0.16   0.41 0.22 4.80 0.25 0.44 0.19 0.39  
Bromperidol [2] 4.03 8.0 N 0.50 10.10   24.00         
Pentobarbital [2] 2.10 8.1 A 0.66 1.30 1.30        0.80   
Flunitrazepam [3] 2.34 1.8 N 0.25 4.54 73.50 4.36 1.46 2.74 1.66 0.40 3.69 4.78 1.03   
Mazapertine [90] 5.05 7.0 WB 0.03 3.15 8.01  0.62  1.52 7.36 20.50 2.31 1.49 1.12 1.55 
Alfentanil [99] 2.20 6.5 WB 0.16 0.71 1.89  0.13 1.18 0.55 0.82 1.00 0.78 0.31 0.18 0.73 
Diazepam [3] 2.87 3.4 WB 0.13 5.12 12.20 5.45 2.13 7.06 5.56 4.15 13.44 5.89 2.77 4.23  
 
a
A: acid, N: neutral, WB: weak base, Z: zwitterion 
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Appendix 5. Sample R codes Random forest, bagging and Rpart 
rm(list = ls(all = TRUE)) 
library(MASS) 
library(RODBC) 
channel <- odbcConnectExcel() 



















pfit<- prune(rpart, cp=   rpart$cptable[which.min(rpart$cptable[,"xerror"]),"CP"])  
























Appendix 6. Sample R codes for generation of final Classification trees by random forest analysis 
with the total dataset 
rm(list = ls(all = TRUE)) 
library(stats) # calling stats library 
tr<-read.csv("DEC15-DT2-code-Final.csv",sep=",") #reading the dataset 
logp<-tr$LogP # reading dataset for variables  
fup<-tr$fup 
doi<-tr$DOI7 #Degree of ionization at pH 7 
vss<-tr$Vss  
Class<-tr$Class  
group<-as.factor(tr$Code_Spleen) # making the membership as a factor variable 




library(randomForest) # calling randomForest library 
rf<-randomForest(group~.,data=trdata[,-6]) #making random forest  
rf # show result of random forest 
result <- rfcv(trdata[,-6], group,cv.fold=20) # finding optimal mtry by random forest cross validation 
result 
cv<-data.frame(group,result$predicted$`5`) # compare the true classification and the classification by random 
forest  





Appendix 7. Dataset for random forest analysis; summary of compound specific physicochemical 
parameters  
Compound LogP pKa Drug Classa fup Vss_rat(L/Kg) Groups 
2,4-Dichlorophenoxyacetic acid [2] 2.43 2.98 A 0.05    3 
Glycyrrhetinic acid [2] 5.50 4.71 A 0.05  1  3 
5-hexyl-5-ethyl barbituric acid [95] 2.79 7.74 A 0.19 0.94 1 2 3 
5-n-butyl-5-ethyl barbituric acids [95] 1.70 7.81 A 0.61 0.68 1 2 3 
5-n-Ethyl-5-ethyl barbituric acids [95] 0.68 7.75 A 0.95 0.51 1 2 3 
5-n-heptyl-5-ethyl barbituric acids [95] 3.64 7.78 A 0.07 1.10 1 2 3 
5-n-Methyl-5-ethyl barbituric acids [95] 0.05 8.11 A 0.99 0.57 1 2 3 
5-nonyl-5-ethyl barbituric acid [95] 4.07 7.82 A 0.01 1.90 1 2 3 
5-octyl-ethyl-barbituric acid[95] 3.82 7.78 A 0.00 1.40 1 2 3 
5-pentyl-5-ethyl barbituric acid[95] 2.20 8.00 A 0.50 0.74 1 2 3 
5-propyl-5-ethyl barbituric acid[95] 0.87 7.77 A 0.87 0.56 1 2 3 
Cefazolin[93] -0.58 2.28 A 0.15 0.40 1 2 3 
Dicloxacillin[93] 2.91 2.88 A 0.03  1  3 
Etodolac-R[103] 3.60 4.70 A 0.00    3 
Etodolac-S[103] 3.60 4.70 A 0.02    3 
Fleroxacin[2] 0.24 6.50 A 0.75 1.30 1 2 3 
Glycyrrhizin[2] 2.80 5.30 A 0.05 0.18 1 2 3 
Hexobarbital[2] 1.74 8.10 A 0.70 1.20 1 2 3 
Penicillin [93] 1.64 2.80 A 0.15 0.24 1 2 3 
Phenobarbital [2] 1.47 7.35 A 0.78 1.02 1 2 3 
Phenytoin[4,97] 2.47 8.23 A 0.12 1.39 1 2 3 
p-Phenylbenzoic acid[104] 2.81 4.20 A 0.03  1  3 
Salicylic acid [94] 2.26 3.00 A 0.40 0.19 1 2 3 
Tenoxicam [9] 1.86 5.30 A 0.02 0.13 1 2 3 
Thiopental[2] 2.85 7.50 A 0.18 0.19 1 2 3 
Tolbutamide [2] 2.34 5.50 A 0.24 0.20 1 2 3 
Valproic acid [2] 2.75 4.60 A 0.37 0.66 1 2 3 
Caffeine[5] 1.29 10.40 B 0.97 0.71  2 3 
Chlorpromazine [2] 5.42 9.70, 6.40 B 0.11 29.00  2 3 
Cocaine[5] 2.30 8.61 B 0.63 2.80 1 2 3 
Disopyramide R-  [85] 2.71 9.92 B 0.24  1  3 
Disopyramide S- [85] 2.71 9.92 B 0.24  1  3 
Flecainide R- [85] 4.65 9.80 B 0.52  1  3 
Flecainide S- [85] 4.65 9.80 B 0.52  1  3 
Flurazepam [2] 3.80 9.79 B 0.50  1  3 
N-Acetylprocainamide  [2] 1.50 9.09 B 0.92    3 
Pethidine [105,106] 2.45 8.59 B 0.15 13.20 1 2 3 
Phencyclidine  [8] 4.96 9.40 B 0.47 12.55 1 2 3 
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Trihexyphenidyl  [2] 4.30 8.70 B 0.37  1  3 
Verapamil R-  [85] 3.79 8.92 B 0.10  1  3 
Verapamil S-  [85] 4.92 8.92 B 0.10  1  3 
Domperidone [89] 3.96 7.89 B 0.09 7.40 1 2 3 
Nebivolol [89] 4.03 8.40 B 0.02 5.20 1 2 3 
Galantamine  [89] 1.09 8.20 B 0.76 5.18 1 2 3 
Lorcainide  [89] 4.16 9.44 B 0.26 4.59 1 2 3 
Fentanyl  [89] 3.94 8.40 B 0.17 3.65 1 2 3 
Loperamide  [89] 5.13 8.86 B 0.02 4.42  2 3 
Cisapride  [89] 4.22 7.90 B 0.08 4.73  2 3 
Ritanserin  [89] 5.20 8.20 B 0.02 8.00 1 2 3 
Prucalopride  [89] 2.26 8.50 B 0.71 4.90 1 2 3 
Sabeluzole  [89] 4.63 7.80 B 0.02 5.85 1 2 3 
Lubeluzole  [89] 4.88 7.60 B 0.01 4.24 1 2 3 
Laniquidar  [89] 5.50 7.90 B 0.00 8.95 1 2 3 
Acebutolol-R [80] 1.79 9.70 B 0.79 9.33 1 2 3 
Acebutolol-S [80] 1.79 9.70 B 0.73 8.90 1 2 3 
Betaxolol-R [80] 2.59 9.40 B 0.53 20.99 1 2 3 
Betaxolol-S [80] 2.59 9.40 B 0.54 19.75 1 2 3 
Biperiden [2] 4.25 8.80 B 0.17 14.00 1 2 3 
Bisoprolol-R [80] 1.87 9.40 B 0.85 6.92 1 2 3 
Bisoprolol-S [80] 1.87 9.40 B 0.85 6.72 1 2 3 
Carvedilol-R [80] 4.19 8.10 B 0.02 1.79 1 2 3 
Carvedilol-S [80] 4.19 8.10 B 0.04 3.36 1 2 3 
Clozapine [2] 3.23 7.50 B 0.50    3 
Cotinine [2] -0.25 8.10 B 0.97 0.43 1 2 3 
Diazepam [3] 2.87 3.40 B 0.15 5.12 1 2 3 
Haloperidol [2] 4.30 8.70 B 0.23 10.00 1 2 3 
Imipramine [53] 4.62 9.50 B 0.24 18.69 1 2 3 
Inaperisone [82] 3.50 8.97 B 0.24 6.35 1 2 3 
Lidocaine [2] 2.44 8.00 B 0.38 2.62 1 2 3 
Metoprolol-R [80] 2.01 9.70 B 0.80 7.87 1 2 3 
Metoprolol-S [80] 2.01 9.70 B 0.81 7.74 1 2 3 
Morphine [83,107] 0.82 8.28 B 0.72 5.18 1 2 3 
Nicotine [2] 1.17 7.80, 3.00 B 0.84 1.53 1 2 3 
Oxprenolol-R [80] 2.18 9.50 B 0.24 2.80 1 2 3 
Oxprenolol-S [80] 2.18 9.50 B 0.36 3.74 1 2 3 
Pentazocine [2] 3.31 8.50 B 0.46 7.66 1 2 3 
Pindolol-R [80] 1.75 9.05 B 0.51 4.32 1 2 3 
Pindolol-S [80] 1.75 9.05 B 0.76 8.59 1 2 3 
Procainamide [2] 0.88 9.20 B 0.92 1.77 1 2 3 
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Promazine [2] 4.55 9.10 B 0.05    3 
Propranolol [2] 3.22 9.41 B 0.08 13.04 1 2 3 
Propranolol-R [80] 3.48 9.50 B 0.02 1.88 1 2 3 
Propranolol-S [80] 3.48 9.50 B 0.13 10.13 1 2 3 
Pyridostigmine [2] -3.73 10.00 B 0.50 0.35 1 2 3 
Quinidine [86] 3.01 10.00, 5.40 B 0.33 8.94 1 2 3 
Theophyllin [2] -0.02 8.81 B 0.90 0.50 1 2 3 
Thioridazine [2] 5.90 9.50 B 0.01    3 
Timolol-S [80] 1.87 9.20, 8.80 B 0.63 5.20 1 2 3 
Verapamil [6] 3.79 8.50 B 0.05 4.40 1 2 3 
Bromperidol [2] 4.03  N 0.50 10.10  2 3 
Fluphenazine [2] 4.20  N 0.50    3 
Ftorafur [9] -0.27  N 0.78 0.34 1 2 3 
Medazepam [2] 3.89  N 0.50  1  3 
Neostigmine [2] -1.65  N 0.50  1  3 
N-Methylpentobarbital [2] 2.69  N 0.50  1  3 
Propofol [2] 3.79  N 0.03 9.90  2 3 
2,3-Dideoxyinosine [2] -1.24  N 0.98 0.51 1 2 3 
Clobazam [2] 2.86  N 0.25 3.29 1 2 3 
Cyclosporin [98] 2.90  N 0.12 3.62 1 2 3 
Digoxin [2] 1.23  N 0.73 0.99 1 2 3 
Ethoxybenzamide [2] 0.80  N 0.59 0.63 1 2 3 
Chlordiazepoxide [9] 2.40 4.70 WB 0.15 1.45 1 2 3 
Prazepam [2] 3.73 3.44 WB 0.50  1  3 
Triazolam [3] 2.40 2.00 WB 0.28 2.24 1 2 3 
Alfentanil [2] 2.20 6.50 WB 0.16 0.71 1 2 3 
Alprazolam [3] 2.21 2.40 WB 0.35 1.98 1 2 3 
Flunitrazepam [9] 2.34 1.80 WB 0.25 3.81 1 2 3 
Midazolam  [3] 3.01 5.87 WB 0.07 2.38 1 2 3 
Sparfloxacin [92] 0.21 5.84, 9.08 Z 0.55 3.42 1 2 3 
Ceftazidime [102] -1.71 2.50,3.80, 1.90 Z 0.90 0.24 1 2 3 
Nalidixic acid [87] 1.10 5.10,3.30 Z 0.29 0.38 1 2 3 
Enoxacin  [87] 0.10 6.10,8.70 Z 0.66 1.57 1 2 3 
Lomefloxacin  [87] -0.30 5.80,9.30 Z 0.72 1.30 1 2 3 
Ofloxacin  [87] -0.40 6.10,8.20 Z 0.92 1.50 1 2 3 
Grepafloxacin [91] 1.17 6.08,9.08 Z 0.59 5.42 1 2 3 
Norfloxacin [2] -1.03 6.60,8.80 Z 0.58 2.05 1 2 3 
Pefloxacin [2] 0.42 6.30,7.60 Z 0.77 2.75 1 2 3 
Pipemidic acid [2] -2.15 7.00,4.90,3.50 Z 0.82 2.31 1 2 3 
Tetracycline [2] -1.30 7.70,9.70,3.30 Z 0.50 2.20 1 2 3 
a
A: acid, B: base, WB: weak base with basic pKa ≤ 7.4, Z: zwitterion  
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Appendix 8. Dataset for random forest analysis; summary of experimentally determined Kps 
Compound Adipose Bone Brain Gut Heart Kidney Liver Lung Muscle Skin Spleen 
2,4-Dichlorophenoxyacetic acid [2] 
  
1.42 
        






0.22 0.1 0.16 0.07 
5-hexyl-5-ethyl barbituric acid [95] 6.14 
 
1.66 1.61 1.56 2.28 3.34 1.07 1.17 2.13 0.84 
5-n-butyl-5-ethyl barbituric acids [95] 1.31 0.98 1.17 1.23 1.45 3.24 2.09 1.05 0.9 1.09 0.36 
5-n-Ethyl-5-ethyl barbituric acids [95] 0.42 0.63 0.68 0.59 0.73 1.71 1.64 0.84 0.66 0.77 0.52 
5-n-heptyl-5-ethyl barbituric acids [95] 5.55 
 
1.13 1.34 1.33 2.05 2.23 1.2 0.93 1.46 1.25 
5-n-Methyl-5-ethyl barbituric acids [95] 0.26 0.98 0.63 0.59 0.68 1.3 1.5 0.73 0.6 0.76 0.7 
5-nonyl-5-ethyl barbituric acid [95] 5.83 
 
2.49 2.04 2.07 4.07 3.76 2.65 0.99 2.76 3.09 
5-octyl-ethyl-barbituric acid[95] 5.13 
 
1.87 1.32 1.47 2.52 3.47 3.06 0.81 1.91 1.87 
5-pentyl-5-ethyl barbituric acid[95] 1.63 0.49 0.91 0.82 0.91 2.27 1.71 0.65 0.72 1.11 0.33 





0.17 0.1 2.77 0.77 0.19 0.09 0.3 
 
Dicloxacillin[93] 
   







0.18 0.12 0.12 





0.45 0.39 0.43 







2 2 1.2 
 
Glycyrrhizin[2] 
    
0.25 
  
0.06 0.06 0.15 0.07 
Hexobarbital[2] 1.6 
  
1.43 1.28 1.5 6 2.81 0.99 0.95 
 
Penicillin [93] 
   
0.97 0.1 3.71 0.25 0.16 0.06 
 
0.1 
Phenobarbital [2] 0.31 
 




0.7 1.24 0.71 1.6 2.3 0.72 0.7 0.94 
 
p-Phenylbenzoic acid[104] 0.06 
 
0.06 0.15 0.23 0.3 0.35 0.28 0.08 0.15 0.1 
Salicylic acid [94] 
 
0.14 0.06 0.66 0.19 0.44 0.23 0.19 0.13 0.27 
 
Tenoxicam [9] 0.02 0.08 0.01 0.17 0.14 0.78 0.86 0.24 0.06 0.12 0.07 
Thiopental[2] 15.5 
 
0.7 1.32 2.59 3.09 2.29 2.96 2.05 1.75 0.53 
Tolbutamide [2] 0.13 
 
0.1 0.12 0.27 0.22 0.3 0.25 0.13 0.22 0.19 
Valproic acid [2] 0.15 
 
0.07 0.45 0.43 1.5 1.8 0.42 0.16 0.47 
 
Caffeine[5] 0.23 0.89 0.6 
 
0.56 0.93 














































        
4.9 
  
N-Acetylprocainamide  [2] 
    
2.17 
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262.28 24.24 5.2 
  




2.19 11.8 8.04 40.98 1.51 
  
Trihexyphenidyl  [2] 76 7.9 21 22 23 
  
74 13 8.1 
 
Verapamil R-  [85] 





Verapamil S-  [85] 















4.71 10.6 14.1 99.7 2.95 
  
Galantamine  [89] 0.48 4.79 1.51 
 
2.28 14.5 2.53 4.42 2.14 1.14 2.92 




2.91 5.68 0.57 19.4 6.5 
 
10.3 




4.54 12.2 3.83 13.6 3.12 
  
Loperamide  [89] 
     
9.3 5 35.9 
   




1.93 7.32 17.1 10.8 
   




10.5 18.6 24 3.02 
  




4.3 17.6 8.77 10.6 4.57 
  
Sabeluzole  [89] 8.41 1.83 5.37 
 
2.45 10.4 37.7 29.2 0.83 2.95 5.48 




9.9 27.7 18.1 2.04 
  




5.82 12 16.8 38.7 7.07 
  
Acebutolol-R [80] 1.1 0.06 0.48 22.43 5.71 23.58 31.48 10.31 4.97 3.01 
 
Acebutolol-S [80] 0.79 0.04 0.36 91.25 4.3 32.7 24.89 6.14 4.45 2.47 
 
Betaxolol-R [80] 2.95 13.2 12.93 40.23 23.59 58.3 130.91 203.52 13.78 6.52 
 
Betaxolol-S [80] 2.86 12.85 13.01 37.8 21.52 54.54 108 182.52 13.55 6.05 
 
Biperiden [2] 67.64 2.28 7.95 12.92 8.04 12.13 
 
86.31 3.69 4.7 
 
Bisoprolol-R [80] 1.03 4.88 1.64 26.52 6.49 24.91 22.78 41.82 5.4 2.18 
 
Bisoprolol-S [80] 1.02 4.43 1.79 25.67 6.69 24.82 22.95 41.99 5.23 2.21 
 
Carvedilol-R [80] 0.8 
   
1.94 1.92 4.52 34 0.81 
  
Carvedilol-S [80] 1.9 
   





        
Cotinine [2] 0.08 
 
0.42 0.64 0.51 0.99 0.64 0.63 0.67 
  




27.2 13.37 10.8 14.3 
  
53.5 29 6.2 
 
Imipramine [53] 7.35 
 
22.99 26.66 21.91 54.19 121.28 141.22 9.91 1.68 57.36 








3.24 3.12 2.73 17.21 11.51 3.8 1.68 2.58 4.79 
Metoprolol-R [80] 1.04 5.18 6.48 12.96 6.89 26.56 40.04 25.56 5.66 3.19 
 
Metoprolol-S [80] 0.98 5.33 6.97 11.22 6.25 26.89 44.59 26.57 5.57 2.92 
 
Morphine [83,107] 





Nicotine [2] 0.32 
 
2.02 1.6 1.12 18.14 4.95 1.24 1.23 1.1 
 




Oxprenolol-S [80] 0.69 2.33 2.48 11.18 4.37 17.62 12.33 21.24 3.89 1.7 
 
Pentazocine [2] 2.5 5.4 4.3 4.7 5.4 20 2.3 27 5.9 4.7 
 
Pindolol-R [80] 0.88 2.71 5.1 26.01 13.87 47.4 14.36 33.58 8.08 2.86 
 
Pindolol-S [80] 0.62 2.29 5.17 18.32 9.27 29.79 7.24 30.32 7.28 2.74 
 











        
Propranolol [2] 
  
14 6.6 7.1 15.3 11.6 16.46 4.3 
 
14.2 
Propranolol-R [80] 0.65 1.39 6.51 6.27 3.86 6.19 5.56 24.24 1.89 1.09 
 
Propranolol-S [80] 2.41 6.73 35.69 23.11 15.75 35.31 29.34 131.7 9.4 5.21 
 
Pyridostigmine [2] 
    


















        
Timolol-S [80] 0.64 1 1.06 20.16 5.36 13.32 7.87 26.96 4.15 1.58 
 
Verapamil [6] 












        
Ftorafur [9] 0.17 
 
0.41 0.36 0.38 0.68 0.39 0.26 0.5 0.4 0.42 
Medazepam [2] 

























        
2.6 
  
Cyclosporin [98] 11.57 3.18 0.79 5.23 4.05 7.99 12.2 5.52 1.35 2.92 5.45 
Digoxin [2] 
   
5.91 1.65 2.07 15.19 2.09 1.4 
  
Ethoxybenzamide [2] 0.71 
 
0.94 0.56 0.99 1.3 
 
0.91 0.81 1.04 0.87 
Chlordiazepoxide [9] 4.31 
 





        
1.8 
  








Alfentanil [2] 1.89 
 
0.13 1.18 0.55 0.82 1 0.78 0.31 0.18 0.73 
Alprazolam [3] 1.08 0.95 1.88 1.67 1.69 3.68 8.39 3.15 2 2.96 
 
Flunitrazepam [9] 73.5 4.36 1.46 2.74 1.66 0.4 3.69 4.78 1.03 
  
Midazolam  [3] 4.62 1.92 2.49 2.81 4.64 3.19 8.51 4.08 0.87 1.96 2.42 
Sparfloxacin [92] 0.18 
  
9.87 2.09 7.55 4.5 2.45 1.93 2.08 
 
Ceftazidime [102] 0.16 
  
0.41 0.22 4.8 0.25 0.44 0.19 0.39 
 
Nalidixic acid [87] 
 
0.29 0.22 0.49 0.49 0.54 0.58 0.33 0.36 0.35 
 




1.07 4.61 3.21 1.14 1.45 1.36 1.63 
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Lomefloxacin  [87] 0.27 1.58 0.22 1.63 1.37 4.84 2.3 1.24 1.61 0.94 1.73 
Ofloxacin  [87] 0.19 1.42 0.24 
 
1.78 6.39 2.04 1.36 1.72 1.19 1.93 
Grepafloxacin [91] 
   
6.06 5.19 15.01 11.46 20.23 3.54 
  
Norfloxacin [2] 







2.36 4.13 5.34 1.94 2.41 
 
3.42 
Pipemidic acid [2] 0.34 2.02 0.13 
 
0.89 7.41 4.61 1.03 1.05 
 
1.35 
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